Advertisement

Herzkrankheiten pp 1073-1145 | Cite as

Klinik der Kardiomyopathien

  • H. Reindell
  • L. Görnandt
  • P. Bubenheimer

Zusammenfassung

Der nosologische Begriff Kardiomyopathie wurde erstmals von Bridgen (1957) im heutigen Sinne angewandt. Er bezeichnete damit Myokarderkrankungen, die nicht durch eine Erkrankung der Coronararterien bedingt waren. Mattingly (1958, 1961, 1970) faßte ähnlich verlaufende, aber auf eine Vielzahl ätiologischer Faktoren zurückführende Erkrankungen des Herzmuskels unter dem Begriff der primären myokärdialen Erkrankungen zusammen. Nach der heute einheitlich angewandten Definition werden mit dem Begriff Kardiomyopathie alle Erkrankungen des Herzmuskels erfaßt, die weder durch eine Coronarerkrankung noch durch eine Hypertonie im großen und kleinen Kreislauf noch durch ein Vitium des Herzens hervorgerufen werden (Grosse-Brockhoff 1971; Kübler et al. 1972, 1973; Loogen u. Kuhn 1975; Kuhn et al. 1977). Die Kardiomyopathien werden unterteilt in primäre oder idiopathische Kardiomyopathien bei unbekannter Ursache und in sekundäre Kardiomyopathien bei bekannter Ursache (Harvey et al. 1964; Harvey u. Segal 1967; Fowler 1964, 1971a, b; Fowler u. Gueron 1965; Edington u. Hütt 1968; Goodwin 1970, 1978; Kochsiek 1975; Kochsiek et al. 1971; Olsen 1972, 1978; Burch et al. 1972; Kuhn et al. 1977; Loogen et al. 1974, 1976; Loogen u. Kuhn 1975; Kuhn u. Loogen 1981).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur (Abschnitt 48.1–48.9)

  1. Abbasi, A.S., McAlpin, R.N., Eber, L.M., Pearce, M.L.: Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation 46, 897 (1972 a).PubMedGoogle Scholar
  2. Abbasi, A.S., Chahine, R.A., McAlpin, R.N., Kattus, A.A.: Echocardiographic study of the left ventricular function in primary congestive cardiomyopathy. Chest 62, 357 (1972 b).Google Scholar
  3. Abelmann, W.H.: Virus and the heart. Circulation 4, 950 (1971).Google Scholar
  4. Abelmann, W.H.: Heavy drinking and the cardiovascular system. J. cardiovasc. Med. 9, 695 (1984).Google Scholar
  5. Adelman, A.G., Shah, P.M., Gramiak, R., et al.: Long-term propranolol therapy in muscular subaortic stenosis. Brit. Heart J. 32, 804 (1970).PubMedGoogle Scholar
  6. Adelman, A.G., Wigle, E.D., Ranganathan, N., Webb, G.D., Kidd, B.S., Bigelow, W.G., Silver, M.D.: The clinical course in muscular subaortic stenosis: A retrospective and prospective study of 60 hemodynamically proved cases. Ann. intern. Med. 77, 515 (1972).PubMedGoogle Scholar
  7. Alexander, C.S.: Idiopathic heart disease. I. Analysis of 100 cases with special reference to chronic alcoholism. Amer. J. Med. 41, 213 (1966).PubMedGoogle Scholar
  8. Alexander, C.S.: The concept of alcoholic myocardiopathy. Med. clin. N. Amer. 52, 1183 (1968).PubMedGoogle Scholar
  9. Alexander, C.S.: Cobalt-beer cardiomyopathy. A clinical pathologic study of twenty-eight cases. Amer. J. Med. 53, (1972).Google Scholar
  10. Alexander, C.S.: Alcoholic cardiomyopathy. Postgrad. Med. J. 58, 127 (1975).Google Scholar
  11. Anschütz, F.: Virus-Myokarditis. Diagnostik 8, 175 (1975).Google Scholar
  12. Anschütz, F., Mende, E.: Die Karditis des akuten rheumatischen Fiebers im Jugend- und Erwachsenenalter. Dtsch. med. Wschr. 93, 7 (1968).PubMedGoogle Scholar
  13. Askanas, A., Udoshi, M., Sadjadi, S.A.: The heart in chronic alcoholism: a noninvasive study. Amer. Heart J. 99, 9 (1980).PubMedGoogle Scholar
  14. Ayuthya, P.S.N., Jayavasu, J., Pongpanich, B.: Coxsackie group B virus and primary myocardial disease in infants and children. Amer. Heart J. 88, 311 (1974).Google Scholar
  15. Bader, H.S.: Contractile tension in the myocardium. Amer. Heart J. 66, 432 (1963).Google Scholar
  16. Barr, P.A., Celermajer, J.M., Bowdler, J.D., et al.: Idiopathic hypertrophic obstructive cardiomyopathy causing severe right ventricular outflow tract obstruction in infancy. Brit. Heart J. 35, 1109 (1973).PubMedGoogle Scholar
  17. Bashour, F.A., McConnel, Skinner, T., Hansen, W.: Myocardial sarcoidosis. Dis. Chest 53, 413 (1968).PubMedGoogle Scholar
  18. Baudet, M., Rigaud, M., Rocha, P., Bardet, J., Bourdarias, J.P.: Reversibility of alcoholic cardiomyopathy with abstention from alcohol. Cardiology 64, 317 (1979).PubMedGoogle Scholar
  19. Behrend, H., et al.: Die Klinik und Diagnostik der Sarkoidose. Internist 10, 293 (1969).PubMedGoogle Scholar
  20. Bemiller, C.E., Pepine, C.J., Rogers, A. K.: Long-term observations in patients with angina and normal coronary arteriograms. Circulation 47, 36 (1973).PubMedGoogle Scholar
  21. Bengtsson, E.: Myocarditis and cardiomyopathy. Cardiologia (Basel) 52, 97 (1968).Google Scholar
  22. Bengtsson, E.: Acute myocarditis and its consequences in Sweden. Postgrad. Med. J. 48, 754 (1972).PubMedGoogle Scholar
  23. Bengtsson, E., Lamberger, B.: Five-year follow-up study of cases suggestive of acute myocarditis. Amer. Heart J. 72, 751 (1966).PubMedGoogle Scholar
  24. Bernheim, P.L.: De l’astolie veineuse dans Fhypertrophie du cceur gauche, par sténose concomitante du ventricle droit. Rev. méd. 30, 785 (1910).Google Scholar
  25. Bertrand, M.: Myocardial function in myocardial disease. In: Disorders of cardiac function ( H.Roskamm, G.Csapo, Hrsg.). New York: Marcel Dekker (to be published 1982 ).Google Scholar
  26. Beuren, A.J., Koncz, J., Kochsiek, K.: Funktionelle Subaortenstenose als Folge einer Kardiomyopathie unbekannter Ursache. Z. Kreisl.-Forsch. 50, 1162 (1961).Google Scholar
  27. Beyer, J., Klinner, W.: Die IHSS als chirurgisch bedeutsame primäre Kardiomyopathie. Z. Kardiol. Suppl. 2, 21 (1975).Google Scholar
  28. Bigelow, W.G., Trimble, A.S., Auger, P., et al.: The ventriculomyotomy operation for muscular subaortic stenosis: A reappraisal. J. thorac cardiovasc. Surg. 52, 514 (1966).PubMedGoogle Scholar
  29. Björk, L.: Die röntgenologische Symptomatologie der Kardiomyopathien. Röntgen-Bl. 30, 432 (1977).Google Scholar
  30. Bland, E.F., Jones, T.D.: Rheumatic fever and rheumatic heart disease. Circulation 4, 386 (1951).Google Scholar
  31. Bliss, H.A., Moffat, J.E., Gautt, C.L.: Effects of chronic oral Propranolol therapy in idiopathic hypertrophic subaortic stenosis. Circulation, Suppl. II, 35/36, 72 (1967).Google Scholar
  32. Blömer, H., Delius, W.: Prognostische Beurteilung von Patienten mit primärer Kardiomyopathie. Internist 16, 548 (1975).PubMedGoogle Scholar
  33. Bollinger, O. von: Über die Häufigkeit und Ursachen der idiopathischen Herzhypertrophie in München. Dtsch. med. Wschr. 10, 180 (1884).Google Scholar
  34. Bolte, H.D.: Diagnostische Wertigkeit des indirekten Immunfluoreszenztests zum Nachweis humoraler Antikörper gegen Myokard. Internist 16, 180 (1975 a).PubMedGoogle Scholar
  35. Bolte, H.D.: Die rheumatische Karditis. Internist 16, 501 (1975 b).PubMedGoogle Scholar
  36. Bolte, H.D.: Entzündliche Herzerkrankungen und Kardiomyopathien. In: Klinische Kardiologie (G.Riecker, Hrsg.), S. 53. Berlin-Heidelberg-New York: Springer 1975c.Google Scholar
  37. Bolte, H.D., Grothey, K.: Cardiomyopathies, related to immunological processes. In: G.Riecker, A.Weber, J.F. Goodwin, Hrsg.), S. 266. Berlin-Heidelberg-New York: Springer 1977.Google Scholar
  38. Bolte, H.D., Schultheiss, P., Cyran, J., Goss, G.: Binding of immunglobulins in the myocardium (biopsies) in cardiomyopathies. In: Myocardiobiopsies (H.D.Bolte, Hrsg.), S. 85. Berlin-Heidelberg-New York: Springer 1980.Google Scholar
  39. Bolte, H.D., Fischer, S., Ludwig, B.: Immunologische Untersuchungsbefunde bei dilativen Kardiomyopathien. Z. Kardiol. 71, 517 (1982).PubMedGoogle Scholar
  40. Bonfiglio, T.H., Atwater, E.C.: Heart disease in patients with seropositive rheumatoid arthritis. Arch, intern. Med. 124, 714 (1969).Google Scholar
  41. Braunwald, E., Ebert, P.A.: Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Amer. J. Cardiol. 10, 489 (1962).PubMedGoogle Scholar
  42. Braunwald, E., Aygen, M.M.: Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood-flow. Amer. J. Med. 35, 7 (1963).PubMedGoogle Scholar
  43. Braunwald, E., Brockenbrough, E.C., Morrow, A.G.: Hypertrophic subaortic stenosis - a broadened concept (editorial). Circulation 26, 161 (1962).PubMedGoogle Scholar
  44. Braunwald, E., Brockenbrough, E.C., Frye, R.L.: Studies on digitalis. V. Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis. Circulation 26, 166 (1962).PubMedGoogle Scholar
  45. Braunwald, E., Marrow, A.G., Cronell, W.F., Aygen, M.M., Hilbish, T.F.: Idiopathic hypertrophic subaortic stenosis: Clinical, hemodynamic and angiographic manifestations. Amer. J. Med. 29, 924 (1960).Google Scholar
  46. Braun Wald, E., Lambrew, C.T., Rockoff, S.D.; Ross, J., Morrow, A.G.: Idiopathic hypertrophic subaortic stenosis. A description of the disease based upon analysis of 64 patients. Circulation Suppl.30/IV, 3 (1964a).Google Scholar
  47. Braunwald, E., Oldham, H.N. jr., Linhart, J.W., Mason, D.T., Fort III, L.: The circulatory response of patients with idiopathic hypertrophic subaortic stenosis to nitroglycerin and to the Valsalva maneuver. Circulation 29, 422 (1964b).PubMedGoogle Scholar
  48. Bridgen, W.: Uncommon myocardial diseases, the non coronary cardiomyopathies, Lancet 1975 II, 1179 u. 1243.Google Scholar
  49. Brock, R.: Functional obstruction of the left ventricle. Guy’s Hosp. Rep. 108, 221 (1957).Google Scholar
  50. Brockenbrough, E.C., Braunwald, E., Morrow, A.G.: A hemodynamic technique for the detection of hypertrophic subaortic stenosis. Circulation 23, 189 (1961).Google Scholar
  51. Bryg, R.J., Pearson, A.C., Williams, G.A., Labovitz, A.J.: Left ventricular systolic and diastolic flow abnormalities determined by Doppler echocardiography in obstructive hypertrophic cardiomyopathy. Amer. J. Cardiol. 59, 925 (1987).PubMedGoogle Scholar
  52. Bubenheimer, P.: Echokardiogramm bei hypertrophischer Myokardiopathie. In: Herzkrankheiten, 2.Aufl. (H.Roskamm, H. Reindell, Hrsg.), S. 1117. Berlin-Heidelberg-New York: Springer 1982.Google Scholar
  53. Bubenheimer, P.: Echokardiogramm bei congestiver und dilatativer Kardiomyopathie: In: Herzkrankheiten, 2. Aufl. (H. Roskamm, H. Reindell, Hrsg.), S. 1128. Berlin-Heidelberg-New York: Springer 1982.Google Scholar
  54. Bubenheimer, R, Samek, L., Schmeisser, H.J., Roskamm, H.: Echocardiographic evaluation of left ventricular function during exercise in untrained young men and athletes. In: Sports Cardiology (T. Lubich, A. Venerando, Hrsg.), S. 787. Bologna: Aulo Gaggi 1978.Google Scholar
  55. Bühner, R., Drings, P., Rossner, E.A.: Klinisch pathologische Aspekte der Adriamycin-induzierten Cardiomyopathie. Verh. dtsch. Ges. inn. Med. 83, 1235 (1977).PubMedGoogle Scholar
  56. Bulkley, B.H., Fortuin, N.J.: Systolic anterior motion of the mitral valve without asymmetric septal hypertrophy. Chest 69, 694 (1976).PubMedGoogle Scholar
  57. Bulkey, B. H., Weisfeldt, M.L., Hutchins, G. M.: Asymmetric septal hypertrophy and myocardial fiber disarray - features of normal, developing and malformed hearts. Circulation 56, 292 (1977).Google Scholar
  58. Burch, G.E.: Theoretic considerations of the time course of pressure developed and volume ejected by the normal and dilated left ventricle during systole. Amer. Heart J. 50, 352 (1955).PubMedGoogle Scholar
  59. Burch, G.E., DePasquale, N.P.: Alcoholic cardiomyopathy. Amer. J. Cardiol. 23, 723 (1969).PubMedGoogle Scholar
  60. Burch, G.E., Giles, T.D.: The role of viruses in the produc-tion of heart disease. Amer. J. Cardiol. 29, 231 (1972).PubMedGoogle Scholar
  61. Burch, G.E., Walsh, J.J., Black, W.C.: Value of prolonged bed rest in management of cardiomegaly. J. Amer. med. Ass. 183, 83 (1963).Google Scholar
  62. Burch, G.E., De Pasquale, N.P., Cronvich, J.A.: Influence of ventricular size on the relationship between contractile and manifest tension. Amer. Heart J. 69, 624 (1965 a).PubMedGoogle Scholar
  63. Burch, G.E., Walsh, J.J., Ferrans, V.J., Hibbs, R.: Prolonged bed rest in the treatment of the dilated heart. Circulation 32, 852 (1965 b).PubMedGoogle Scholar
  64. Burch, G. E., Shih-Chien Sein, K-Ch chu, Sohal, R.S., Colcolough, H.J.: Interstitial and coxsackie B myocarditis in infants and children. A comparative study of 50 autopsied hearts. J. Amer. med. Ass. 203, 55 (1968).Google Scholar
  65. Burch, G.E., Harb, J.M., Colcolough, H.L., Tsui, C.Y.: The effect of prolonged consumption of beer, wine and ethanol on the myocardium of the mouse. Johns Hopkins med. J. 129, 130 (1971).PubMedGoogle Scholar
  66. Burch, G.E., Giles, T.D., Tsui, C.Y.: Postpartal cardiomyopathy. Cardiovasc. Clin. 4, 270 (1972).PubMedGoogle Scholar
  67. Burkart, F., Jenzer, H.R.: Der Arbeitsversuch zur Beurteilung von Kardiomyopathien. Schweiz, med. Wschr. 98, 1241 (1968).Google Scholar
  68. Cambridge, G., MacArthur, C.G.C., Waterson, A.P., Goodwin, J.F., Oakley, C.M.: Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Brit. Heart J. 41, 692 (1971).Google Scholar
  69. Canedo, M.I., Frank, M.J., Abdulla, A.M.: Rhythm disturbances in hypertrophic cardiomyopathy: Prevalence, relation to symptoms and management. Amer. J. Cardiol. 45, 848 (1980)PubMedGoogle Scholar
  70. Carr, D., Friesen, H.G.: Growth hormone and insulin binding to human liver. J. clin. Endocrinol. Metab. 42, 484 (1976).PubMedGoogle Scholar
  71. Cherian, G., Brockington, J.F., Shah, P.M., Oakley, C.M., Goodwin, J.F.: Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Amer. J. Cardiol 18, 481 (1966).Google Scholar
  72. Cherian, G., Brockington, J.F., Shah, P.M., Oakley, C.M., Goodwin, J.F.: Beta-adrenergic blockade in patients with hypertrophic obstructive cardiomyopathy. Amer. Heart. J. 73, 140 (1967).PubMedGoogle Scholar
  73. Chiaramida, S.A., Goldman, M.A., Zema, M.J., Pizzarello, R.A., Goldberg, H.M.: Real-time cross-sectional echocardiographic diagnosis of infiltrative cardiomyopathy due to amyloid. J. clin. Ultrasound 8, 58 (1980).PubMedGoogle Scholar
  74. Child, J.S., Krivokapich, J., Abbasi, A.S.: Increased right ventricular wall thickness on echocardiography in amyloid infiltrative cardiomyopathy. Amer. J. Cardiol. 44, 1391 (1979).PubMedGoogle Scholar
  75. Chung, K.J., Manning, J. A., Gramiak, R.: Echocardiography in coexisting hypertrophic subaortic stenosis and fixed left ventricular outflow obstruction. Circulation 49, 673 (1974).PubMedGoogle Scholar
  76. Clark, C.E., Henry, W.L., Epstein, S.E.: Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. New Engl. J. Med. 289, 709 (1973).PubMedGoogle Scholar
  77. Cohen, L.S., Braunwald, E.: Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade. Circulation 35, 847 (1967).PubMedGoogle Scholar
  78. Cohen, J., Effat, H., Goodwin, J.F., Oakley, C.M., Steiner, R.E.: Hypertrophic obstructive cardiomyopathy. Brit. Heart J. 26, 16 (1964).PubMedGoogle Scholar
  79. Cohen, M.V., Cooperman, L.B., Rosenblum, R.: Regional myocardial function in idiopathic hypertrophic subaortic stenosis - an echocardiographic study. Circulation 52, 842 (1975).PubMedGoogle Scholar
  80. Come, P.C., Bulkley, B.H., Goodman, Z.D., Hutchins, G.M., Pitt, B., Fortuin, N.J.: Hypercontractile cardiac states stimulating hypertrophic cardiomyopathy. Circulation 55, 901 (1977).PubMedGoogle Scholar
  81. Cooley, D.A., Leachman, R.D., Hallman, G.L., et al.: Idiopathic hypertrophic subaortic stenosis: Surgical treatment including mitral valve replacement. Arch. Surg. 103, 606 (1971).PubMedGoogle Scholar
  82. Corya, B.C., Rasmussen, S., Feigenbaum, H., Knobel, S.B., Black, M.J.: Systolic thickening and thinning of the septum and posterior wall in patients with coronary artery disease, congestive cardiomyopathy and atrial septal defect. Circulation 55, 109 (1977).PubMedGoogle Scholar
  83. Cote, M., Davignon, A., Elias, G., et al.: Hemodynamic findings in Friedreich’s ataxia. Can. J. neurol. Sci. 3, 333 (1976).PubMedGoogle Scholar
  84. Criley, J.M., Lewis, K.B., White, R.I. jr., et al.: Pressure gradients without obstruction: A new concept of “hypertrophic subaortic stenosis. ” Circulation 32, 881 (1965).PubMedGoogle Scholar
  85. Criley, J. M., Blaufuss, A. H., Abbasi, A.S.: Nonobstructive IHSS. Circulation 52, 963 (1975).PubMedGoogle Scholar
  86. Darsee, J.R., Nutter, D.O., Hopkins, L.C., Heymsfield, S.B.: Neurogenic skeletal myopathy in patients with primary cardiomyopathy. Circulation 59, 492 (1979).PubMedGoogle Scholar
  87. D’Cruz, I. A., Lalmalani, G.G., Sambasivan, V., Cohen, H.C., Glick, G.: The superiority of mitral E point-ventricular septum separation to other echocardiographic indicators of left ventricular performance. Clin. Cardiol. 2, 140 (1979).PubMedGoogle Scholar
  88. Delius, W., Sebening, H., Oversohl, K., Weghmann, N., Wirtzfeld, A.: Verlaufsbeobachtungen bei Paitienten mit kongestiver Kardiomyopathie. Z. Kardiol. Suppl. 2, 19 (1975).Google Scholar
  89. Denny, F.W., Ayoub, E.M., Dillon, H.C. jr., et al.: Prevention of rheumatic fever: A statement by the Rheumatic Fever Committee of the Council on Rheumatic Fever and Congenital Heart Disease of the American Heart Association. Circulation 43, 983 (1971).Google Scholar
  90. Dickhuth, H.-H., Simon, G., Kindermann, W., Wilberg, A., Keul, J.: Echokardiographische Untersuchungen bei Sportlern verschiedener Sportarten und Untrainierten. Z. Kardiol. 68, 49 (1979).Google Scholar
  91. Dinsmore, R.E., Sanders, Ch.A., Harthorne, J.W.: Mitral regurgitation in idopathic hypertrophic subaortic stenosis. New Engl. J. Med. 275, 1225 (1966).PubMedGoogle Scholar
  92. Doerr, W.: Entzündliche Erkrankungen des Myokard. Verh. dtsch. Ges. Path. 51, 67 (1967).Google Scholar
  93. Doerr, W.: Morphologie der Myokarditis. Verh. dtsch. Ges. inn. Med. 77, 301 (1971).PubMedGoogle Scholar
  94. Doerr, W.: Organpathologie, Bd. I. Stuttgart: Thieme 1974.Google Scholar
  95. Doerr, W., Rossner, J.A., Dittgen, R., Rieger, P., Derks, H., Berg, G.: Cardiomyopathie, idiopathische und erworbene Formen und Ursachen. Sitzungsber. Heidelb. Akad. Wiss., math.-naturw. Kl., 5.Abh., S. 477. Berlin-Heidelberg-New York: Springer 1976.Google Scholar
  96. Domenicucci, S., Lazzeroni, E., Roelandt, J., Ten Cate, F.J., Vletter, W.B., Arntzenius, A.C., Das, S.K.: Progression of hypertrophic cardiomyopathy. A cross sectional echocardiographic study. Brit. Heart J. 53, 405 (1985).PubMedGoogle Scholar
  97. Dye, C.L., Rosenbaum, D., Lowe, J.C., Behnko, R.H., Genovese, P.P.: Primary myocardial disease. Part. I. Clinical features. Ann. intern. Med. 58, 426 (1963).Google Scholar
  98. Edington, G.M., Hütt, M.S.R.: Idiopathic cardiomegaly: General and pathology. Cardiologia (Basel) 52, 33 (1968).Google Scholar
  99. Eggebrecht, R.F., Kleiger, R.E.: Echocardiographic patterns in scleroderma. Chest 71, 47 (1977).PubMedGoogle Scholar
  100. Epstein, S.E., Rosing, D.R.: Verapamil: Its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation 64, 437 (1981).PubMedGoogle Scholar
  101. Epstein, S.E., Henry, W.L., Clark, C.E., Roberts, W.C., Maron, B.J., Ferrans, V.J., Redwood, D.R., Morrow, A.G.: Asymmetric septal hypertrophy. Ann. intern. Med. 81, 650 (1974).Google Scholar
  102. Falcone, D.M., Moore, D., Lambert, E.C.: Idiopathic hypertrophic cardiomyopathy involving the right ventricle. Amer. J. Cardiol. 19, 735 (1967).PubMedGoogle Scholar
  103. Fassbender, H.G.: Nosologische Typen des rheumatischen Granuloms und ihre biologische Bedeutung. Frankfurt. Z. Pathol. 72, 586 (1963).Google Scholar
  104. Fassbender, H.G.: Zwei unterschiedliche Formen pathologisch-anatomischer Gewebsprozesse bei primär chronischer Polyarthritis. Verh. dtsch. Ges. Rheumatol. 1, 222 (1969).PubMedGoogle Scholar
  105. Fassbender, H.G.: Spezifische und unspezifische Struktur entzündlich-rheumatischer Erkrankungen. Med. Klin. 2152 (1970).Google Scholar
  106. Feigenbaum, H.: Echokardiographie. In: Echokardiographie, 2. Aufl. ( G. Autenrieth, Hrsg.). Erlangen: Perimed 1985.Google Scholar
  107. Feizi, Ö., Emanuel, R.: Echocardiographic spectrum of hypertrophic cardiomyopathy. Brit. Heart J. 37, 1286 (1975).PubMedGoogle Scholar
  108. Feizi, Ö., Farrer-Brown, G., Emanuel, R.: Familial study of hypertrophic cardiomyopathy and congenital aortic valve disease. Amer. J. Cardiol. 41, 956 (1978).PubMedGoogle Scholar
  109. Ferrans, V.J., Hibbs, R., Birch, G. et al.: Myocardial degeneration in cardiac sarcoidosis. Amer. Heart J. 69, 159 (1965).PubMedGoogle Scholar
  110. Ferrans, V.J., Morrow, A.G., Roberts, W.C.: Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. Circulation 45, 769 (1972).PubMedGoogle Scholar
  111. Ferrans, V.J., Massumi, R.A., Shugoll, E.J., Ali, N., Roberts, W.C.: Ultrastructural studies on myocardial biopsies in 45 patients with obstructive or congestive cardiomyopathy. In: Cardiomyopathies. (E.Bajusz, G.Rona, Hrsg.). S. 231. München: Urban & Schwarzenberg 1974.Google Scholar
  112. Fiddler, G.I., Tajik, A.J., Weidman, W.H., et al.: Idiopathic hypertrophic subaortic stenosis in the young. Amer. J. Cardiol. 42, 793 (1978).PubMedGoogle Scholar
  113. Fiedler, A.: Über akute interstitielle Myokarditis. Vortr. Ges. f. Natur- u. Heilk., Dresden 9.10. 1897, ausführlich in: Festschr. Feier d. fünfzigj. Bestehens d. Stadtkrankenhauses Dresden-Friedrichstadt. Dresden: W.Baensch 1899.Google Scholar
  114. Fishbein, M.C., Blaufuss, A.H., Zamboli, L., Criley, J.M., Laks, M.M.: Myocardial arterioles in “Syndrome x”. Circulation Suppl. 2, 90 (1975).Google Scholar
  115. Flamm, M.D., Harrison, D.C., Hancock, E.W.: Muscular subaortic stenosis: Prevention of outflow obstruction with propranolol. Circulation 38, 846 (1968).PubMedGoogle Scholar
  116. Fleckenstein, A.: Stoffwechselprobleme bei der Myokard-Insuffìzienz. Verh. dtsch. Ges. Pathol. 51, 15 (1967).PubMedGoogle Scholar
  117. Fleming, H.: Myocardial sarcoidosis. Lancet 1973 I, 106.Google Scholar
  118. Fowler, N.O.: Classification and differential diagnosis of the myocardiopathies. Progr. cardiovasc. Dis. 7, 1 (1964).Google Scholar
  119. Fowler, N.O.: Differential diagnosis of cardiomyopathies. Progr. cardiovasc. Dis. 14, 113 (1971a).Google Scholar
  120. Fowler, N.O.: Autoimmune heart disease. Circulation 44, 159 (1971b).PubMedGoogle Scholar
  121. Fowler, N.O., Gueron, M.: Primary myocardial disease. Circulation 32, 830 (1965).PubMedGoogle Scholar
  122. Frank, M.J., Abdulla, A.M., Canedo, M.I., et al.: Long-term medical management of hypertrophic obstructive cardiomyopathy. Amer. J. Cardiol. 42, 993 (1978).PubMedGoogle Scholar
  123. Frank, S., Braunwald, E.: Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation 37, 759 (1968).PubMedGoogle Scholar
  124. Frenzel, H., Kasper, M., Kuhn, H., Lösse, B., Reifschneider, G., Hort, W.: Licht- und elektronenmikroskopische Befunde in Früh- und Spätstadien der Herzinsuffizienz. Untersuchungen an Endomyokardbiopsien von Patienten mit latenter (LCM) und dilatativer (DCM) Kardiomyopathie. Z. Kardiol. 74, 135 (1985).PubMedGoogle Scholar
  125. Freundlich, I.M., McMurray, J.T., Lehman, J.S.: Idiopathic hypertrophic subaortic stenosis. Amer. J. Roentgenol. 100, 284 (1967).PubMedGoogle Scholar
  126. Frey, N.: Häufung von Coxsackie-Virus-B-Myokarditiden im Ruhrgebiet 1973/74. Med. Welt 26, 1275 (1975).PubMedGoogle Scholar
  127. Frye, R.L., Kincaid, O.W., Swan, H.J.C., et al.: Results of surgical treatment of patients with diffuse subvalvular aortic stenosis. Circulation 32, 52 (1965).PubMedGoogle Scholar
  128. Fuster, V., Gersh, B.J., Giuliani, E.R., Tajik, A.J., Brandenburg, R.O., Frye, R.L.: The natural history of idiopathic dilated cardiomyopathy. Amer. J. Cardiol. 47, 525 (1981).PubMedGoogle Scholar
  129. Ghosh, P., et al.: Myocardial sarcoidosis. Brit. Heart J. 34, 769 (1972).PubMedGoogle Scholar
  130. Giuliani, E.R., Tajik, A.J., Frye, R.L., et al.: Idiopathic hypertrophic subaortic stenosis (IHSS) and associated coronary artery disease (abstract). Circulation 46 (suppl 2), 156 (1972).Google Scholar
  131. Goodman, D.J., Harrison, D.C., Popp, R.L.: Echocardiographic features of primary pulmonary hypertension. Amer. J. Cardiol. 33, 438 (1974).PubMedGoogle Scholar
  132. Goodwin, J.F.: Congestive and hypertrophic cardiomyopathies. Lancet 1970 I, 731.Google Scholar
  133. Goodwin, J.F.: Prospects and predictions for the cardiomyopathies. Circulation 50, 210 (1974).PubMedGoogle Scholar
  134. Goodwin, J. F.: Cardiomyopathy classification, part 2. In: The Heart. (J.W.Hurst, Hrsg.), S. 1556. New York: McGraw-Hill 1978.Google Scholar
  135. Goodwin, J.F.: Hypertrophic cardiomyopathy: A disease in search of its own identity. Amer. J. Cardiol. 45, 177 (1980).PubMedGoogle Scholar
  136. Goodwin, J.F., Oakley, C.M.: The cardiomyopathies. Brit. Heart J. 34, 545 (1972).PubMedGoogle Scholar
  137. Goodwin, J.F., Gordon, H., Hollman, A., Bishop, M.B.: Clinical aspects of cardiomyopathy. Brit. med. J. 1961 I, 69.Google Scholar
  138. Gore, I., Saphir, O.: Myocarditis. A classification of 1402 cases. Amer. Heart J. 34, 827 (1967). Gorlin, R.J., Anderson, R.C., Blaw, M.: Multiple lentigines syndrome: complex comprising multiple lentigines, electrocardiographic conduction abnormalities, ocular, hyperteloarism, pulmonary stenosis, abnormalities of genitalia, retardation of growth, sensorineural deafness, and autosomal dominant hereditary pattern. Amer. J. Dis. Child 117, 652 (1969).Google Scholar
  139. Gramiak, R., Shah, P.M., Kramer, D.H.: Ultrasound cardiography: Contrast studies in anatomy and function. Radiology 92, 939 (1969).PubMedGoogle Scholar
  140. Graser, I.: Rheumatische Erkrankungen im Kindesalter. Ergebn. inn. Med. Kinderheilk. 25, 102 (1967).PubMedGoogle Scholar
  141. Grist, N.R., Bell, E.J.: Coxsackie viruses and the heart. Amer. Heart J. 77, 295 (1969).PubMedGoogle Scholar
  142. Grodzinski, E., Kreutz, F., Blümchen, G., Borer, J.S.: Über das Verhalten der Ruhe- und Belastungs-Auswurffraktion (EF) bei Herzinfarktpatienten vor und nach vierwöchigem Training. Vergleich zu einer Kontrollgruppe. Z. Kardiol. 72, 105 (1983).PubMedGoogle Scholar
  143. Grodzinski, E., Fentrop, T., Scharf-Bornhofen, E., Keller, T., Bierck, G., Borer, J.S., Schoop, W., Blümchen, G.: Bedeutung der Auswurffraktion (EF) in Ruhe und bei Belastung mit Hilfe der Radionuklidventrikulographie für die Prognose von Herzinfarktpatienten. Vergleich mit anderen Untersuchungsmethoden. Z. Kardiol. 74, 525 (1985).PubMedGoogle Scholar
  144. Grosse-Brockhoff, F.: Zur Klassifizierung, Ätiologie und Pathogenese der Myokardiopathien. Dtsch. med. Wschr. 96, 659 (1971).PubMedGoogle Scholar
  145. Gulotta, S.J., Hamby, R.I., Aronson, A.L., et al.: Coexistent idiopathic hypertrophic subaortic stenosis and coronary arterial disease. Circulation 46, 890 (1972).PubMedGoogle Scholar
  146. Hagemann, G.J.: Elektrokardiogramm, Herzgröße und Hämodynamik in Ruhe und unter Belastung bei primärer chronischer Kardiomyopathie. Habil. Freiburg/Breisgau 1976.Google Scholar
  147. Hagemann, G.J.: Sarkoidose von Herz und Gefäßen. In: Sarkoidose ( K.Wurm, Hrsg.), Stuttgart-New York: Thieme 1979.Google Scholar
  148. Hagemann, G.J.: Herz und Gefäße. In: Sarkoidose (K.Wurm, Hrsg.), S. 136. Stuttgart-New York: Thieme 1983.Google Scholar
  149. Hagemann, G.J., Wurm, K.: Electrocardiographic findings in sarcoidosis. 7. Congress in sarcoidosis. Card. 1978.Google Scholar
  150. Hagemann, G.J., Reindell, H., Schareck, W., Wink, K., Barmeyer, J.: Herzvolumen und Hämodynamik (Ruhe, Belastung) bei erworbenen Myokardiopathien. Verh. dtsch. Ges. inn. Med. 82, 1040 (1976).PubMedGoogle Scholar
  151. Hamby, R.I., Apiado, O.U., Khan, A.H.: Hemodynamics and left ventricular pressure-volume changes in primary myocardial disease. Circulation 37/38 (Suppl.VI), 93 (1968).Google Scholar
  152. Hamby, R.I., Catangay, P., Apiado, O.U., Khan, A.H.: Primary myocardial disease. Clinical hemodynamic and angiographic correlates in fifty patients. Amer. J. Cardiol. 25, 625 (1970)PubMedGoogle Scholar
  153. Hanrath, P., Schweizer, P., Bleifeld, W., Effert, S.: Differentialdiagnose kongestiver und hypertropher Myokardiopathien mittels Echokardiographie. Z. Kardiol. Suppl. 2, 12 (1975).Google Scholar
  154. Hanrath, P., v. Essen, R., Bleifeld, W., Effert, S.: Idiopathisch hypertrophe subaortale Stenose bei valvulärer Aortenklappenerkrankung—Diagnostik mittels Echokardiographie. Z. Kardiol. 65, 964 (1976).PubMedGoogle Scholar
  155. Hanrath, P., Schweizer, P., Bleifeld, W., von Essen, R., Effert, S.: Familiäre asymmetrische Septumhypertrophie mit und ohne Obstruktion. Dtsch. med. Wschr. 102, 751 (1977).PubMedGoogle Scholar
  156. Hanrath, P., Montz, R., Mathey, D., Verbringer, H., Kupper, W., Knop, J., Bleifeld, W., Schneider, C.: Comparison between Thallium 201 myocardial szintigraphy, myocardial lactate metabolism and coronary angiography in hypertrophic obstructive cardiomyopathy. Circulation 57/58, II–130 (1978).Google Scholar
  157. Hanrath, P., Mathey, D., Siegert, R., Augustin, J., Bleifeld, W.: Abnormes Relaxations- und Füllverhalten des linken Ventrikels bei unterschiedlichen Hypertrophieformen. Z. Kardiol. 68, 214 (1979).PubMedGoogle Scholar
  158. Hanrath, P., Mathey, D., Siegert, R., et al.: Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: An echocardiographic study. Amer. J. Cardiol. 45, 15 (1980).PubMedGoogle Scholar
  159. Hanrath, P., Mathey, D., Kremer, P., Sonntag, F., Bleifeld, W.: Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy. Amer. J. Cardiol. 45, 1258 (1980).PubMedGoogle Scholar
  160. Hardarson, T., Curiel, R., De La Calzada, C. S., Goodwin, J.F.: Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 1973 II, 1462.Google Scholar
  161. Harrison, D., Braunwald, E., Glich, G., Mason, D.T., Chidsey, C.A., Ross jr., J.: Effects of ß-adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation 29, 84 (1964).PubMedGoogle Scholar
  162. Harvey, W.P., Segal, J.P.: Primary myocardial disease. Postgrad. Med. 42, 144 (1967).PubMedGoogle Scholar
  163. Harvey, W.P., Segal, J.P., Gurel, T.: The clinical spectrum of primary myocardial disease. Progr. cardiovasc. Dis. 7, 1 (1964).Google Scholar
  164. Heinecker, R.: Über die Häufigkeit kardialer Beteiligung bei Influenzainfektion. Verh. dtsch. Ges. inn. Med. 65, 788 (1959).PubMedGoogle Scholar
  165. Henning, H., O’Rourke, R.A., Crawford, M.H., Righetti, A., Karliner, J.S.: Inferior myocardial infarction as a cause of asymmetric septal hypertrophy. Amer. J. Cardiol. 41, 817 (1978).PubMedGoogle Scholar
  166. Henry, W.L., Clark, Ch.E., Epstein, S.E.: Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 47, 225 (1973 a).PubMedGoogle Scholar
  167. Henry, W.L., Clark, C.E., Epstein, S.E.: Asymmetric septal hypertrophy (ASH): The unifying link in the IHSS disease spectrum. Circulation 47, 827 (1973 b).PubMedGoogle Scholar
  168. Henry, W.L., Clark, C.E., Glancy, D.L., Epstein, S.E.: Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. New. Engl. J. Med. 288, 989 (1973 c).PubMedGoogle Scholar
  169. Henry, W.L., Clark, C.E., Roberts, W.C., Morrow, A.G., Epstein, S. E.: Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Circulation 50, 447 (1974).PubMedGoogle Scholar
  170. Henry, W.L., Clark, C.E., Griffith, J.M., Epstein, S.E.: Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy. Amer. J. Cardiol. 35, 337 (1975).PubMedGoogle Scholar
  171. Henry, W.L., Morganroth, J., Pearlman, A.S., Clark, C.E., Redwood, D.R., Itscoitz, S.B., Epstein, S. E.: Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 53, 273 (1976).PubMedGoogle Scholar
  172. Henry, W.L., Nienhuis, A.W., Wiener, M., Miller, D.R., Canale, V.C., Piomelli, S.: Echocardiographic abnormalities in patients with transfusion-dependent anemia and secasondary myocardial iron deposition. Amer. J. Med. 64, 547 (1978).PubMedGoogle Scholar
  173. Hess, O.M.: Klinik, Diagnostik und Therapie der Kardiomyopathien. Schweiz. Rundschau Med. (Praxis) 73, 26, 817 (1984).Google Scholar
  174. Hess, O.M., Krayenbühl, H.P.: Das Elektrokardiogramm bei den Kardiomyopathien. Schweiz, med. Wschr. 112, 333 (1982).Google Scholar
  175. Hess, O.M., Turina, J., Goebel, N., Krayenbühl, H.P.: Funktionelle Gruppen der primären, nicht obstruktiven Kardiomyopathie. Z. Kardiol. Suppl. 2, 10 (1975).Google Scholar
  176. Hess, O.M., Turina, J., Krayenbühl, H.P.: Zur Diagnostik der Kardiomyopathien. Dtsch. med. Wschr. 102, 623 (1977).PubMedGoogle Scholar
  177. Hess, O.M., Goebel, N.H., Luescher, H., Schneider, J., Angehrn, W., Krayenbühl, H.P.: Left ventricular function in patients with hypertrophic nonobstructive cardiomyopathy. Europ. J. Cardiol. 9/2, 129 (1979).Google Scholar
  178. Hirschmann, S.Z., Hammer, G.S.: Coxsackie virus myopericarditis. A microbiological and clinical review. Amer. J. Cardiol. 34, 224 (1974).Google Scholar
  179. Holzmann, M.: Die Bewertung der elektrokardiographischen Befunde bei der Myokarditis. Regensb. Jb. ärztl. Fortbild. 14, 198 (1966).Google Scholar
  180. Hopf, R.: Die hypertroph obstruktive Kardiomyopathie (HOCM) und ihre Behandlung mit Kalzium-Antagonisten. Habilitationsarbeit, Frankfurt/Main 1980.Google Scholar
  181. Hopf, R., Keller, M., Kaltenbach, M.: Die Behandlung der hypertrophen obstruktiven Kardiomyopathie mit Verapamil. Verh. dtsch. Ges. Inn. Med. 82, 1053 (1976).Google Scholar
  182. Hopf, R., Kober, G., Kaltenbach, M.: Die hypertroph obstruktive Kardiomyopathie (HOCM). Internistische Welt 3, 394 (1980).Google Scholar
  183. Hopf, R., Kaltenbach, M., Kober, G.: Verapamil in the treatment of hypertrophic obstructive cardiomyopathy. In: Calcium antagonism in cardiovascular therapy - experience with verapamil (A.Zanchetti, D.M.Krikler, Hrsg.), S. 353. Amsterdam-Oxford-Princeton: Excerpta Medica 1981.Google Scholar
  184. Hopf, R., Lemke, R., Kober, G., Kaltenbach, M.: Klinische Ergebnisse der calciumantagonistischen Therapie bei Patienten mit hypertroph obstruktiver Kardiomyopathie. In: Calcium Antagonismus (A. Fleckenstein, Hrsg.), S. 172. Berlin- Heidelberg-New York: Springer 1980.Google Scholar
  185. Hopf, R., Hopf, M., Kober, G., Kaltenbach, M., Riemann, H.: Wertigkeit von Röntgenbefund und EKG in der Vorfelddiagnostik primärer Myokarderkrankungen. Z. Kardiol. Suppl. 2, 32 (1975).Google Scholar
  186. Hort, W: Morphologie der akuten und chronischen Herzdilatation und Herzinsuffizienz. Verh. dtsch. Ges. Kreisl.-Forsch. 34, 1 (1968).Google Scholar
  187. Hort, W.: Morphologie der Kardiomyopathien. Röntgenblätter 9, 425 (1977).Google Scholar
  188. Hudson, R.E.: The cardiomyopathies: Order from chaos. Amer. J. Cardiol. 25, 70 (1970).PubMedGoogle Scholar
  189. Hurst, J.W., Logue, R.B.: The heart arteries and veins, 3rd ed. New York: McGraw-Hill 1974.Google Scholar
  190. Hutchins, G.M., Bulkley, B.H.: Catenoid shape of the interventricular septum: Possible cause of idiopathic hypertrophic subaortic stenosis. Circulation 58, 392 (1978).PubMedGoogle Scholar
  191. Jackson, G., Richardson, P. J., Atkinson, L., Armstrong, P., Oram, S.: Angina with normal coronary arteriograms, value of coronary sinus lactate estimation in diagnosis and treatment. Brit. Heart J. 40, 976 (1978).PubMedGoogle Scholar
  192. Johansen, A.: Isolated myocarditis versus myocardial sarcoidosis. Acta path, microbiol. scand. 67, 15 (1966).Google Scholar
  193. Jones, M., Ferrans, V.J., Morrow, A.G., Roberts, W.C.: infrastructure of crista supraventricularis muscle in 37 patients with congenital heart disease associated with right ventricular outflow tract obstruction. Circulation 51, 39 (1975).PubMedGoogle Scholar
  194. Julian, O.C., Dye, W.S., Javid, H., Hunter, J.A., Muenster, J.J., Najafi, H.: Apical left ventriculotomy in subaortic stenosis due to a fibromuscular hypertrophy. Circulation 31, Suppl. 1–45 (1965).Google Scholar
  195. Jüngst, B.K: Die myokardiale Sarcoidose. Z. Kinderheilk. 95, 53 (1966).PubMedGoogle Scholar
  196. Kaltenbach, M.: Therapie der hypertrophischen obstruktiven Cardiomyopathie mit Calciumantagonisten. In: Cardiomyopathies and myocardial biopsy ( M. Kaltenbach, F. Loogen, E.G.J. Olsen, Hrsg.) Berlin-Heidelberg-New York: Springer 1977.Google Scholar
  197. Kaltenbach, M., Hopf, R.; Konservative medikamentöse Behandlung der hypertrophen Myokardiopathie. Z. Kardiol. 71, 795 (1982).PubMedGoogle Scholar
  198. Kaltenbach, M., Hopf, R., Keller, M.: Calciumantagonistische Therapie bei hypertroph obstruktiver Kardiomyopathie. Dtsch. med. Wschr. 101, 1284 (1976).PubMedGoogle Scholar
  199. Kaltenbach, M., Hopf, R., Petersen, Y., Kober, G.: Verminderung des Koronararterienquerschnitts unter konservativer Therapie der hypertroph obstruktiven Kardiomyopathie. Verh. dtsch. Ges. Kreisl.-Forsch. 43, 358 (1977).Google Scholar
  200. Kaltenbach, M., Hopf, R., Kober, G., Bussmann, W.-D., Keller, M., Petersen, Y.: Verapamil treatment of hypertrophic obstructive cardiomyopathy. In: Cardiomyopathy and myocardial biopsy (M.Kaltenbach, F.Loogen, E.G.J. Olsen, Hrsg.), S. 316. Berlin-Heidelberg-New York: Springer 1978.Google Scholar
  201. Kaltenbach, M., Hopf, R., Kober, G., Bussmann, W.-D., Keller, M., Petersen, Y.: Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Brit. Heart J. 42, 35 (1979).PubMedGoogle Scholar
  202. Kaplan, M.H., Bolandi, R., Ratika, L., Blair, S.: Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. Association with cardiac failure. New Engl. J. Med. 271, 637 (1964).PubMedGoogle Scholar
  203. Kazamias, T.M., Gander, M.P.: Left ventricular wall motion disorders, functional left ventricular aneurysms. Amer. J. Cardiol. 32, 151 (1973).PubMedGoogle Scholar
  204. Kemp, H.G., Vokonas, S., Cohn, P.F., Gorlin, R.: The anginal syndrome associated with normal coronary arteriograms. Amer. J. Med. 54, 735 (1973).PubMedGoogle Scholar
  205. King, J.F., demaria, A.N., Reis, R.L., Bolton, m. R., Dunn, M.I., Mason, d. t.: Echocardiographic assessment of idiopathic hypertrophic subaortic stenosis. Chest 64, 723 (1973).Google Scholar
  206. King, J.F., DeMaria, A.N., Miller, R.R., Hilliard, G.K., Zelis, R., Mason, D.T.: Markedly abnormal mitral valve motion without simultaneous intraventricular pressure gradient due to uneven mitral-septal contract in idiopathic hypertrophic subaortic stenosis. Amer. J. Cardiol. 34, 360 (1974).PubMedGoogle Scholar
  207. Kirklin, J. W., Ellis jr., F.H.: Surgical relief of diffuse subvalvular aortic stenosis. Circulation 24, 739 (1961).PubMedGoogle Scholar
  208. Knieriem, H.-J.: Electron microscopic findings in congestive cardiomyopathy. In: Cardiomyopathies and myocardial biopsy ( M. Kaltenbach, F. Loogen, E.G.J. Olsen, Hrsg.). Berlin-Heidelberg-New York: Springer 1977.Google Scholar
  209. Knieriem, H.-J.: Myokardiopathien. In: Lehrbuch der speziellen Pathologie (F. Büchner, E. Grundmann, Hrsg.), S. 38. München-Wien-Baltimore: Urban & Schwarzenberg 1979.Google Scholar
  210. Knieriem, H.-J., Kuhn, H., Breithardt, G.: Zur Diagnostik der primären Kardiomyopathien mit Hilfe der Myokardbiopsie. Z. Kardiol. Suppl 2, 26 (1975).Google Scholar
  211. Knieriem, H.-J., Stroobandt, R., Meyer, H., Bourgeois, M.: Hypertrophie non-obstructive cardiomyopathy caused by disorder of the myofiber texture. Virchows. Arch. 367, 209 (1975)Google Scholar
  212. Kober, G., Becker, H.J., Bussmann, W.D., Kaltenbach, M.: Die Myokardbiopsie in der Diagnostik der Kardiomyopathien. Technische Aspekte und Komplikationen. Z. Kardiol. Suppl. 2, 23 (1975).Google Scholar
  213. Köberle, I.: Chagas heart disease-pathology. Cardiologica (Basel) 52, 82 (1968).Google Scholar
  214. Kochsiek, K.: Klassifizierung der Kardiomyopathien. Z. Kardiol. Suppl. 2, 2 (1975).Google Scholar
  215. Kochsiek, K., Larbig, D., Harmjanz, D.: Die hypertrophische obstruktive Kardiomyopathie. Experimentelle Medizin, Pathologie und Klinik, Bd. 35. Berlin: Springer 1971a.Google Scholar
  216. Kochsiek, K., Tauchert, M., Strauer, B.E., Heiss, H.W.: Koronarreserve und O2-Verbrauch bei hypertrophischer obstruktiver Kardiomyopathie. Verh. dtsch. Ges. inn. Med. 77, 880 (1971b).PubMedGoogle Scholar
  217. Köhler, E., Kuhn, H., Bluschke, V., Haerten, K., Loogen, F.: Seltene echokardiographische Befunde bei hypertrophischer obstruktiver Kardiomyopathie. Z. Kardiol. 68, 271 (1979 a).Google Scholar
  218. Köhler, E., Thurow, J., Kuhn, H., Neuhaus, C., Bluschke, V., Bosiu, M.: Klinische und echokardiographische Untersuchungen zur familiären Verbreitung der hypertrophisch obstruktiven (HOCM) und hypertrophisch nicht obstruktiven (HNCM) Kardiomyopathie. Z. Kardiol. 68, 511 (1979b).PubMedGoogle Scholar
  219. Konecke, L.L., Feigenbaum, H., Chang, S., Corya, B.C., Fischer, J.C.: Abnormal mitral valve motion in patients with elevated left ventricular diastolic pressures. Circulation 47, 989 (1973).PubMedGoogle Scholar
  220. Koontz, C.H.; Ray, C.G.: The role of coxsackie group virus infections in sporadic myopericarditis. Amer. Heart 82, 750 (1971).Google Scholar
  221. Körfer, R., Schulte, H.D., Bircks, W.: Zur operativen Behandlung der idiopathischen hypertrophischen Subaortenstenose (IHSS). Z. Kardiol. Suppl. 2, 2 (1975).Google Scholar
  222. Kostis, J.B., Moreyra, A.E., Natarajan, N., et al.: The pa-thophysiology and diverse etiology of septal perforator compression. Circulation 59, 913 (1979).PubMedGoogle Scholar
  223. Krajcer, Z., Orzan, F., Pechacek, L.W., Garcia, E., Leachman, R.D.: Early systolic closure of the aortic valve in patient with hypertrophic subaortic stenosis and discrete subaortic stenosis. Amer. J. Cardiol. 41, 823 (1978).PubMedGoogle Scholar
  224. Krasnow, N., Stein, R.A.: Hypertrophic cardiomyopathy in the aged. Amer. Heart J. 96, 326 (1978).PubMedGoogle Scholar
  225. Krelhaus, W., Kuhn, H., Loogen, F.: Todesfälle bei hypertrophischer obstruktiver Myokardiopathie. In: Cardiomyopathies and myocardial biopsy ( M. Kaltenbach, F. Loogen, EG.J. Olsen, Hrsg.), Berlin-Heidelberg-New York: Springer 1977Google Scholar
  226. Kreulen, T.H., Gorlin, R., Herman, M.V.: Ventriculographic patterns and hemodynamics in primary myocardial disease. Circulation 47, 299 (1973).PubMedGoogle Scholar
  227. Kjronik, G., Litpak, V., Mösslacher, H., Slany, J., Ehrenböck, R.: Echokardiographische Kriterien für die Differentialdiagnose zwischen kongestiver Kardiomyopathie und koronarer Herzkrankheit bei Patienten mit Kardiomegalie. Herz/Kreisl. 11, 483 (1979).Google Scholar
  228. Kronik, G., Mösslacher, H., Schmoliner, R.: Differentialdiagnose zwischen diffusen Myokarderkrankungen und koronarer Herzkrankheit mit Hilfe der zweidimensionalen Echokardiographie. Herz/Kreisl. 3, 113 (1981).Google Scholar
  229. Kübler, W., Kuhn, H., Loogen, F.: Zur klinischen Einteilung der Cardiomyopathien. Dtsch. med. Wschr. 97, 1834 (1972).PubMedGoogle Scholar
  230. Kübler, W., Kuhn, H., Loogen, F.: Die Cardiomyopathien. Z. Kardiol. 62, 3 (1973).PubMedGoogle Scholar
  231. Kübler, W., Zebe, H., Tillmanns, D., Zekl, G.: Die congestive Cardiomyopathie. Z. Kardiol. Suppl. 2, 4 (1975).Google Scholar
  232. Kuhn, E.: Die Bedeutung der Vererbung bei Kardiomyopathien. Klin. Wschr. 55, 673 (1977).PubMedGoogle Scholar
  233. Kuhn, H.: Invasive Diagnostik bei Kardiomyopathien. Verh. dtsch. Ges. Herz-Kreisl.-Forsch. 47, 217 (1981).Google Scholar
  234. Kuhn, H.: Left ventricular hypertrophy in clinical practice: Cardiomyopathies. Europ. Heart J. 3, 187 (1982).Google Scholar
  235. Kuhn, H.: Treatment of hypertrophic cardiomyopathies. In: Verapamil treatment of hypertrophic cardiomyopathy (E. Epstein, M. Kaltenbach, Hrsg.), S. 160. Berlin-Heidelberg-New York: Springer 1982.Google Scholar
  236. Kuhn, H., Loogen, F.: Die Anwendung von Betarezeptorenblockern bei hypertrophischer obstruktiver Kardiomyopathie (HOCM). Internist 19, 527 (1978 b).Google Scholar
  237. Kuhn, H., Loogen, F.: Die Wirkung von Alkohol auf das Herz einschließlich der Alkoholkardiomyopathie. Internist 19, 97 (1978 c).Google Scholar
  238. Kuhn, H., Loogen, F.: Erkrankungen des Myokards. In: Kardiologie in Klinik und Praxis, Bd. II ( H. P. Krayenbühl, W. Kübler, Hrsg.). Stuttgart: Thieme 1981.Google Scholar
  239. Kuhn, H., Krelhaus, W, Loogen, F.: Indication for surgical treatment of hypertrophic obstructive cardiomyopathy. In: Cardiomyopathies and Myocardial Biopsy ( M. Kaltenbach, F. Loogen, E.G.J. Olsen, Hrsg.). Berlin-Heidelberg-New York: Springer 1977.Google Scholar
  240. Kuhn, H., Hust, M.H., Breithardt, G., Wiebringhaus, E.: Zur Frage der kardiodepressiven Wirkung geringer Mengen von Alkohol bei Normalpersonen und Patienten mit koronarer Herzerkrankung. Z. Kardiol. 65, 1071 (1976).PubMedGoogle Scholar
  241. Kuhn, H., Haensch, R., Lösse, B., Jehle, J.: Hypertrophische obstruktive Cardiomyopathie und Lentiginosis. Dtsch. med. Wschr. 18, 679 (1977 a).Google Scholar
  242. Kuhn, H., Breithardt, G., Knieriem, H.-J., Loogen, F.: En-domyocardial catheter biopsy in heart disease of unknown etiology. In: Cardiomyopathy and Myocardial Biopsy (M. Kaltenbach, F. Loogen, E.G.J. Olsen, Hrsg.), S. 121. Berlin-Heidelberg-New York: Springer 1978a.Google Scholar
  243. Kuhn, H., Thelen, U., Köhler, E., Lösse, B.: Die hypertrophische nicht obstruktive Kardiomyopathie (HNCM) - klinische, hämodynamische, elektro-, echo- und angiographische Untersuchungen. Z. Kardiol. 69, 457 (1980).PubMedGoogle Scholar
  244. Kuhn, E., Köhler, E., Hort, W., Frenzel, H.: Concealed myocardial storage disease (Fabry’s disease): Pitfalls in the diagnosis of hypertrophic non obstructive cardiomyopathy. Circulation 66, II–117 (1982).Google Scholar
  245. Kuhn, H., Loogen, F., Breithardt, G., Seipel, L., Krelhaus, W.: Die Kardiomyopathien. In: Handbuch der medizinischen Radiologie (L. Diethelm, O. Olsson, F. Strnad, H. Vieten, A. Zuppinger, Hrsg.), S. 261. Berlin-Heidelberg- New York: Springer 1977.Google Scholar
  246. Kuhn, H., Thelen, U., Leuner, C., Köhler, E., Bluschke, V.: Langzeitbehandlung der hypertrophischen nicht obstruktiven Kardiomyopathie (HNCM) mit Verapamil. Z. Kardiol. 69, 669 (1980).PubMedGoogle Scholar
  247. Kuhn, H., Lösse, B., Becker, R., Curtius, J.M., Köhler, E., Loogen, F.: Die congestive (dilatative) Kardiomyopathie aus allgemein klinischer Sicht. Z. Kardiol. 70, 604 (1981).Google Scholar
  248. Kuhn, H., Breithardt, G., Knieriem, H.-J., Loogen, F., Both, A., Schmidt, W.A., Stroobandt, R. p: Die Bedeutung des Elektrokardiogramms und der endomyokardialen Katheterbiopsie für Diagnose und Verlaufsbeobachtung der congestiven Kardiomyopathie. Verh. dtsch. Ges. inn. Med. 81, 211 (1975b).PubMedGoogle Scholar
  249. Kuhn, H., Breithardt, G., Knieriem, H.-J., Köhler, E., Lösse, B., Seipel, L., Loogen, F.: Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy. Postgrad. Med. J. 54, 451 (1978b).PubMedGoogle Scholar
  250. Kuhn, H., Becker, R., Fischer, J., Curtius, J.M., Lösse, B., Hort, W., Loogen, F.: Untersuchungen zur Ätiologie, zum Verlauf und zur Prognose der dilatativen Kardiomyopahie (DCM). Z. Kardiol. 71, 497 (1982).PubMedGoogle Scholar
  251. Kuhn, H., Breithardt, G., Knieriem, H.-J., Loogen, F., Both, A., Schmidt, W.A., Stroobandt, R., Gleichmann, U.: Die Bedeutung der endomyokardialen Katheterbiopsie für die Diagnostik und Beurteilung der Prognose bei congestiver Cardiomyopathie. Dtsch. med. Wschr. 100, 717, 743 (1975 a).Google Scholar
  252. Kuhn, H., Gietzen, F., Mercier, J., Lösse, B., Köhler, E., Schulte, H.D., Birks, W., Loogen, F.: Untersuchungen zur Klinik, zum Verlauf und zur Prognose verschiedener Formen der hypertrophischen Kardiomyopathie. Z. Kardiol. 72, 83 (1983).PubMedGoogle Scholar
  253. Kunkel, B., Kober, G., Lapp, H., Leuschner, U., Kaltenbach, M.: Vergleich klinischer, licht- und elektronenmikroskopischer Befunde bei Kardiomyopathien. Z. Kardiol. Suppl. 2, 27 (1975).Google Scholar
  254. Kunkel, B., Kober, G., Lapp, H., Leuschner, U., Kaltenbach, M.: Klinische, licht- und elektronenmikroskopische Befunde bei frühen und fortgeschrittenen Formen kongestiver Kardiomyopathien. Z. Kardiol. 66, 198 (1977).PubMedGoogle Scholar
  255. Kunkel, B., Lapp, H., Kober, G., Kaltenbach, M.: Correlations between clinical and morphologic findings and natural history in congestive cardiomyopathy. In: Cardiomyopathy and Myocardial Biopsy (M. Kaltenbach, F. Loogen, E.G.J. Olsen, Hrsg.), S. 271. Berlin-Heidelberg-New York: Springer 1978.Google Scholar
  256. Kunkel, B., Schneider, M., Kober, G., Bussmann, W.D., Hopf, R., Kaltenbach, M.: Die Morphologie der Myokardbiopsie und ihre klinische Bedeutung. Z. Kardiol. 71, 787 (1982).PubMedGoogle Scholar
  257. Larter, W.E., Allen, H.D., Sahn, D.J., Goldberg, S.J.: The asymmetrically hypertrophied septum. Further differentiation of its causes. Circulation 53, 19 (1976).PubMedGoogle Scholar
  258. Lerner, A.M., Wilson, F.M.: Virus myocardiopathy. Progr. med. Virol. 15, 63 (1973).Google Scholar
  259. Levander-Lindgren, M.: Studies in myocarditis. IV. Late prognosis. Cardiología (Basel) 47, 209 (1965).Google Scholar
  260. Lewis, B.S., Gotsman, M.S.: Selective coronary angiography in primary myocardial disease. Brit. Heart J. 35, 165 (1973).PubMedGoogle Scholar
  261. Linhart, J.W., Taylor, W.J.: Bacterial endocarditis in a patient with idiopathic hypertrohic subaortic stenosis. Circulation 34, 595 (1966).PubMedGoogle Scholar
  262. Linzbach, A.J.: Heart failure from the point of view of quantitative anatomy. Amer. J. Cardiol. 5, 370 (1960 a).PubMedGoogle Scholar
  263. Linzbach, A.J.: Die pathologische Anatomie der Herzinsuffizienz. In: Handbuch der inneren Medizin (H.Schwiegk, Hrsg.), Bd.9/1, S. 706. Berlin-Göttingen-Heidelberg: Springer 1960b.Google Scholar
  264. Linzbach, A.J.: Eröffnungsrede des Tagungsvorsitzenden. Verh. dtsch. Ges. Kreisl.-Forsch. 34, 38 (1968).Google Scholar
  265. Linzbach, A.J., Kyrieleis, C.: Strukturelle Analyse chronisch insuffizienter menschlicher Herzen. In: Herzinsuffizienz. Internationales Symposium, 2.-5.11. 1957, Hinterzarten ( H. Reindell, J. Keul, E. Doll, Hrsg.), S.U. Stuttgart: Thieme 1968.Google Scholar
  266. Lockhart, A., Charpentier, A., Bourdarias, J.P., et al.: Right ventricular involvement in obstructive cardiomyopathies: Hemodynamic studies in 13 cases. Brit. Heart J. 28, 122 (1966).PubMedGoogle Scholar
  267. Löffler, W.: Endocarditis parietalis fibroplastica mit Bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweiz, med. Wschr. 66, 817 (1936).Google Scholar
  268. Loogen, F.: Klinik, Therapie und Prognose der hypertrophen obstruktiven Kardiomyopathie. Symposion Bundesgesundheitsamt: Zur kritischen Bewertung experimenteller Befunde auf dem Herz-Kreislauf-Sektor für den Menschen. Berlin 1986.Google Scholar
  269. Loogen, F.: Mittlerer Druckgradient 50 mmHg bezogen auf 260 Untersuchungen: Literaturangaben und eigene Beobachtungen. Persönl. Mitteilung 1987.Google Scholar
  270. Loogen, F., Kuhn, H.: Kardiomyopathien ungeklärter Ätiologie (sog. primäre Kardiomyopathien). Internist 16, 540 (1975).PubMedGoogle Scholar
  271. Loogen, F., Krelhaus, W., Kübler, W.: Natural history of hypertrophic obstructive cardiomyopathy: Observations on 107 patients. In: Cardiomyopathies (E. Bajuz, G. Rona, Hrsg.), S. 629. München: Urban & Schwarzenberg 1974.Google Scholar
  272. Loogen, F., Krelhaus, W., Kuhn, H.: Die hypertrophische obstruktive Myokardiopathie (HOCM). Z. Kardiol. Suppl. 2, 3 (1975).Google Scholar
  273. Loogen, F., Krelhaus, W., Kuhn, H.: Die hypertrophische obstruktive Kardiomyopathie. Münch, med. Wschr. 118, 745 (1976).Google Scholar
  274. Loogen, F., Kuhn, H., Krelhaus, W.: Follow-up studies in patients with hypertrophic obstructive cardiomyopathy. 7th European Congress of Cardiology, Amsterdam 1976.Google Scholar
  275. Loogen, F., Kuhn, H., Neuhaus, L.K.: Störungen der Ventrikelfunktion bei Kardiomyopathien. Verh. dtsch. Ges. Kreisl.-Forsch. 42, 63 (1976a).Google Scholar
  276. Loogen, F., Krelhaus, W., Kuhn, H.: Verlaufsbeobachtungen der hypertrophischen obstruktiven Cardiomyopathie. Z. Kardiol. 65, 511 (1976 b).PubMedGoogle Scholar
  277. Loogen, F., Kuhn, H., Krelhaus, W.: Follow up studies in patients with hypertrophic obstructive cardiomyopathy. In: Cardiomyopathies and myocardial biopsy ( M. Kaltenbach, F. Loogen, E.G.J. Olsen, Hrsg.). Berlin-Heidelberg-New York: Springer 1977.Google Scholar
  278. Loogen, F., Kuhn, H., Krelhaus, W.: Natural history of hypertrophic obstructive cardiomyopathy and the effects of therapy. In: Cardiomyopathy and myocardial biopsy (M. Kaltenbach, F. Loogen, E.G.J. Olsen, Hrsg.), S. 286. Berlin-Heidelberg-New York: Springer 1978.Google Scholar
  279. Lorell, B.H., Aldermann, E.L., Mason, J.W.: Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Amer. J. Cardiol. 42, 143 (1978).PubMedGoogle Scholar
  280. Lorell, B.H., Paulus, W.J., Grossman, W., et al.: Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 65, 499 (1982).PubMedGoogle Scholar
  281. Lösse, B., Kuhn, H., Loogen, F.: Klinische und hämodynamische Effekte von Verapamil bei hypertrophischer obstruktiver Kardiomyopathie. Z. Kardiol. 71, 813 (1982).PubMedGoogle Scholar
  282. Lösse, B., Kuhn, H., Loogen, F.: Functional results in medically and surgically treated patients with hypertrophic obstructive cardiomyopathy. In: Hypertrophic Cardiomyopathy (M. Kaltenbach, S.E. Epstein, Hrsg.), S. 251. Berlin-Heidelberg-New York: Springer 1982.Google Scholar
  283. Lösse, B., Kuhn, H., Bircks, W., Loogen, F.: Hemodynamic effects of different therapeutic trials in hypertrophic obstructive cardiomyopathy - verapamil, propranolol, and surgical therapy. Europ. Heart J. 2, (Suppl. A), 59 (1981).Google Scholar
  284. Lösse, B., Kuhn, H., Rafflenbeul, D., Krönert, H., Bircks, W., Loogen, F.: Verapamil im Vergleich zu Propranolol und chirurgischer Therapie bei obstruktiver Kardiomyopathie (HOCM). Z. Kardiol. 70, 626 (1981) (abstract).Google Scholar
  285. Lösse, B., Kuhn, H., Krönert, H., Rafflenbeul, D., Köhler, E., Schicha, H., Feinendegen, L.E.: Hämodynamische und radiokardiographische Belastungsuntersuchungen bei Patienten mit komplettem Linksschenkelblock und normal großem Herzen. Z. Kardiol. 68, 304 (1979).PubMedGoogle Scholar
  286. Lösse, B., Kuhn, H., Rafflenbeul, D., Krönert, H., Hort, W., Feinendegen, L.E., Loogen, F.: Scintigraphic myocardique au thallium-201 chez des patients ä coronaires et ventriculographies normales. Ann. Cardiol. Angeiol. 29, 265 (1980).Google Scholar
  287. Lösse, B., Kuhn, H., Krönert, H., Rafflenbeul, D., Kirschner, P., Schulte, H.D., Loogen, F.: Hämodynamische Auswirkungen konservativer und operativer Therapie bei hypertrophischer obstruktiver Kardiomyopathie. Z. Kardiol. 69, 470 (1980).PubMedGoogle Scholar
  288. MacArthur, C.G.C., Binbrek, A.S., Chetty, S., Sanderson, J.E., Fitchett, D.H., Goodwin, J.F., Oakley, C.M.: The effect of left ventricular function, arrhythmias and evidence of previous viral infection on the prognosis of congestive cardiomyopathy. In: Congestive cardiomyopathy (J.F. Goodwin, A. Hjalmarson, E.G.J. Olsen, Hrsg.), S. 236. Schweden: Acta cardiovascular 1981.Google Scholar
  289. Maire, R., Hess, O.M., Pult, I., Schneider, J., Krayenbühl, H.P.: Die äthylische Kardiomyopathie: ein Vergleich zur dilatativen Kardiomyopathie. Schweiz. Rundschau Med. (Praxis) 76, 3, 37 (1987).Google Scholar
  290. Maisch, B.: Die dilatative Kardiomyopathie. Herz u. Gefäße 4, 73 (1984).Google Scholar
  291. Marcus, G.B., Popp, R.L., Stinson, E.B.: Coronary-artery disease with idiopathic hypertrophic subaortic stenosis. Lancet 1974 I, 901.Google Scholar
  292. DeMaria, A.N., Bommer, W., Lee, G., Mason, D.T.: Value and limitations of two dimensional echocardiography in assessment of cardiomyopathy. Amer. J. Cardiol. 46, 1224 (1980).Google Scholar
  293. Maron, B.J., Roberts, W.C.: Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 59, 689 (1979).PubMedGoogle Scholar
  294. Maron, B.J., Epstein, S.E., Roberts, W.C.: Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Amer. J. Cardiol. 43, 1086 (1979).PubMedGoogle Scholar
  295. Maron, B.J., Roberts, W.C., Epstein, S.E.: Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation 65, 1388 (1985).Google Scholar
  296. Maron, B.J., Henry, W.L., Roberts, W.C., Epstein, S.E.: Comparison of echocardiographic and necropsy measurements of ventricular wall thickness in patients with and without disproportionate septal thickening. Circulation 55, 341 (1977).PubMedGoogle Scholar
  297. Maron, B.J., Edwards, J.E., Henry, W.Lt, et al.: Asymmetric septal hypertrophy (ASH) in infancy. Circulation 50, 809 (1974).PubMedGoogle Scholar
  298. Maron, B.J., Redwood, D.R., Roberts, W.C., Henry, W.L., Morrow, A.G., Epstein, S.E.: Tunnel subaortic stenosis - Left ventricular outflow tract obstruction produced by fibromuscular tubular narrowing. Circulation 54, 404 (1976).PubMedGoogle Scholar
  299. Maron, B.J., Henry, W.L., Clark, C.F., Redwood, D.R., Roberts, W.C., Epstein, S.E.: Asymmetric septal hypertrophy in childhood. Circulation 53, 9 (1976).PubMedGoogle Scholar
  300. Maron, B.J., Roberts, W.C., Edwards, J.E., McAllister, jr. H.A., Foley, D.D., Epstein, S.E.: Sudden death in patients with hypertrophic cardiomyopathy: Characterization of 26 patients without functional limitation. Amer. J. Cardiol. 41, 803 (1978).PubMedGoogle Scholar
  301. Maron, B.J., Merrill, W.H., Freier, P. A., Kent, K.M., Epstein, S.E., Morrow, A.G.: Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 57, 1205 (1978).PubMedGoogle Scholar
  302. Maron, B.J., Roberts, W.C., McAllister, jr. H.A., Rosing, D.R., Epstein, S.E.: Sudden death in young athletes. Circulation 62, 218 (1980).PubMedGoogle Scholar
  303. Maron, B.J., Ferrans, V.J., Henry, W.L., Clark, C.E., Redwood, D.R., Roberts, W.C., Morrow, A.G., Epstein, S.E.: Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH): Light and electronmicroscopic findings. Circulation 50, 436 (1974).PubMedGoogle Scholar
  304. Maron, B.J., Clark, C.E., Henry, W. L., Fokuda, T., Edwards, J.E., Mathews, E.C., Redwood, D.R., Epstein, S.E.: Prevalence and characteristics of disproportionate ventricular septal thickening in patients with aquired or congenital heart disease. Circulation 55, 489 (1977).PubMedGoogle Scholar
  305. Maron, B.J., Lipson, L.C., Roberts, W.C., et al.: “Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death. Amer. J. Cardiol. 41, 1133 (1978).PubMedGoogle Scholar
  306. Maron, B.J., Tajik, A.J., Ruttenberg, H.D., et al.: Hypertrophic cardiomyopathy in infants: Clinical features and natural history. Circulation 65, 7 (1982).PubMedGoogle Scholar
  307. Maron, B.J., Roberts, W.C., Epstein, S.E.: Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients. Circulation 65, 1388 (1982).PubMedGoogle Scholar
  308. Martin, R.P., Rakowski, H., French, J., Popp, R.L.: Idiopathic hypertrophic subaortic stenosis viewed by wide-angle, phased-array echocardiography. Circulation 59, 1206 (1979).PubMedGoogle Scholar
  309. Massie, B.M., Schiller, N.B., Ratshin, R.R., Parmley, W.W.: Mitral septal separation: New echocardiographic index of left ventricular function. Amer. J. Cardiol. 39, 1008 (1977).PubMedGoogle Scholar
  310. Mathes, P., Sebening, H., Delius, W., Wirtzfeld, A.: Regionales Kontraktionsverhalten bei kongestiver Kardiomyopathie. Z. Kardiol. Suppl. 2, 9 (1975).Google Scholar
  311. Mathes, P., Delius, W., Sebening, H., Wirtzfeld, A., Blomer, H.: Das regionale Kontraktionsverhalten der linken Herzkammer bei kongestiver Cardiomyopathie. Dtsch. med. Wschr. 101, 995 (1976).PubMedGoogle Scholar
  312. Matsui, Y., Kazvoiswai, T., Taukibana, T., Frive, T.: Clinico-pathological study of total myocardial sarcoidosis. Ann. N. Y. Acad. Sci. 278, 455 (1976).PubMedGoogle Scholar
  313. Mattingly, T.W.: The clinical and hemodynamic features of primary myocardial disease. Trans. Amer. clin. climatol. Ass. 70, 132 (1958).Google Scholar
  314. Mattingly, T.W.: Clinical features and diagnosis of primary myocardial disease. Mod. Cone, cardiovasc. Dis. 30, 677 (1961).Google Scholar
  315. Mattingly, T. W.: Diseases of the myocardium (cardiomyopathies): The viewpoint of a clinical cardiologist. Amer. J. Cardiol. 25, 79 (1970).PubMedGoogle Scholar
  316. May, G.: Virusatiologie der Myokarditis. Diagnostik 8, 182 (1975).Google Scholar
  317. McDonald, I.G., Feigenbaum, H., Chang, S.: Analysis of left ventricular wall motion by reflected ultrasound. Application to assessment of myocardial function. Circulation 46, 14 (1972).PubMedGoogle Scholar
  318. McKenna, W.J., Chetty, S., Oakley, C.M., Goodwin, J.F.: Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Amer. J. Cardiol. 45, 1 (1980).PubMedGoogle Scholar
  319. Meessen, H.: Structural basis of myocardial hypertrophy. Brit. Heart J. Suppl. 33, 94 (1971 a).Google Scholar
  320. Meessen, H.: Morphologie der Myokardhypertrophie. Verh. dtsch. Ges. inn. Med. 77, 43 (1971b).PubMedGoogle Scholar
  321. Meessen, H.: Über Herzhypertrophie. Lebensversicherungsmedizin 26, 102 (1974).PubMedGoogle Scholar
  322. Meessen, H., Poche, R.: Beiträge zur pathologischen Anatomie der Fallotschen Fehler und zur idiopathischen Herzhypertrophie. Dtsch.-engl. med. R. 4, 73 (1967).Google Scholar
  323. Meinertz, T., Hohnloser, S., Zehender, M., Geibel, A., Just, H.: Plötzlicher Herztod - wie erkennt man gefährdete Patienten? Z. Kardiol. 76, Suppl. 2 (1987).Google Scholar
  324. Menapace, F.J., Hammer, W.J., Kessler, K.K., Ritzer, T., Bove, A.A., Warner, H.H., Spann, J.F.: Echocardiographic measurements of left ventricular wall thickness in weight lifters: A problem with the definition of ASH. Amer. J. Cardiol. 39, 276 (1977).Google Scholar
  325. v.Mengden, H.-J., Reck, R., Lorey-Ammann, S., Strasser, R.: Das Elektrokardiogramm bei Kardiomyopathien. Herz/ Kreisl. 12, 631 (1982).Google Scholar
  326. Menges, jr. H., Brandenburg, R.O., Brown, jr. A.L.: The clinical, hemodynamic, and pathologic diagnosis of muscular subvalvular aortic stenosis. Circulation 24, 1126 (1961).Google Scholar
  327. Messer, J.V., Neill, W.A.: The oxygen supply of human heart. Amer. J. Cardiol. 9, 384 (1962).PubMedGoogle Scholar
  328. Messmer, B.: Hypertroph-obstruktive Kardiomyopathie - Wann ein Fall für den Chirurgen? Med. Trib. 17 (1986).Google Scholar
  329. Mikhail, J.R., et al.: Abnormal electrocardiographic findings in sarcoidosis. Proc. VI ICS Univ. Tokyo Press 365 (1975).Google Scholar
  330. Mintz, H.S., Kotler, M.N., Segal, B.L., Parry, W.R.: Systolic anterior motion of the mitral valve in the absence of asymmetric septal hypertrophy (Abstract). Circulation 53/54 (Suppl. II), 191 (1976).Google Scholar
  331. Mintz,. H.S., Kotler, M.N., Segal, B.L., Parry, W.R.: Systolic anterior motion of the mitral valve in the absence of asymmetric septal hypertrophy. Circulation 57, 256 (1978).Google Scholar
  332. Mirsky, I., Cohn, P.F., Levine, J.A., Gorlin, R., Hermann, M.V., Kreulen, T.H., Sonnenblick, E.H.: Assessment of left ventricular stiffness in primary myocardial disease and coronary artery disease. Circulation 50, 128 (1974).PubMedGoogle Scholar
  333. Moreyra, E., Klein, J.J., Shinada, H., Segal, B.L.: Idiopathic hypertrophic subaortic stenosis diagnosed by reflected ultrasound. Amer. J. Cardiol. 23, 32 (1969).PubMedGoogle Scholar
  334. Morganroth, J., Henry, W.L., Maron, B.J., Clark, C.E., Epstein, S.E.: Idiopathic left ventricular hypertrophy. Echo-cardiographic evidence against its existence. New Engl. J. Med. 290, 1047 (1974).PubMedGoogle Scholar
  335. Morganroth, J., Maron, B.J., Henry, W.L., Epstein, S.E.: Comparative left ventricular dimensions in trained athletes. Ann. intern. Med. 82, 521 (1975).PubMedGoogle Scholar
  336. Morrow, A.G.: Hypertrophic subaortic stenosis: Some physiologic concepts and the role of operative treatment. Arch. Surg. 99, 677 (1969).PubMedGoogle Scholar
  337. Morrow, A.G.: Hypertrophic subaortic stenosis: Operative methods utilized to relieve left ventricular outflow obstruction. J. thorac. cardiovasc. Surg. 76, 423 (1978).PubMedGoogle Scholar
  338. Morrow, A.G., Braunwald, E.: Functional aortic stenosis: A malformation characterized by resistance to left ventricular outflow without anatomic obstruction: Circulation 20, 181 (1959).PubMedGoogle Scholar
  339. Morrow, A.G., Brockenbrough, E.C.: Surgical treatment of idiopathic hypertrophic subaortic stenosis: Technic and he-modynamic results of subaortic ventriculomyotomy. Ann. Surg. 154, 181 (1961).PubMedGoogle Scholar
  340. Morrow, A.G., Fisher, R.D., Fogarty, T.J.: Isolated hypertrophic obstruction to right ventricular outflow: Clinical hemodynamic, and angiographic findings before and after operative treatment. Amer. Heart J. 77, 814 (1969).PubMedGoogle Scholar
  341. Morrow, A.G., Reitz, B.A., Epstein, S.E., Henry, W.L., Conkle, D.M., Itscoitz, S.B., Redwood, D.R.: Operative treatment in hypertrophic subaortic stenosis: Techniques and the results of pre- and postoperative assessments in 83 patients. Circufätion 52, 88 (1975).Google Scholar
  342. Morrow, A.G., Koch, J.-R, Maron, B.J., et al.: Left ventricu-lar myotomy and myectomy in patients with obstructive hy-pertrophic cardiomyopathy and previous cardiac arrest. Amer. J. Cardiol. 46, 313 (1980).PubMedGoogle Scholar
  343. Murgo, J.R, Alter, B.R., Dorethy, J.R., et al.: Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy. J. clin. Invest. 66, 1369 (1980).PubMedGoogle Scholar
  344. Nanda, N.C., Gramiak, R, Shah, P.M., Stewart, S., De Weese, J.A.: Echocardiography in the diagnosis of idiopathic hypertrophic subaortic stenosis co-existing with aortic valve disease. Circulation 50, 752 (1974).PubMedGoogle Scholar
  345. Neufeld, H.N., Ongley, RA., Edwards, J.E.: Combined congenital subaortic stenosis and infundibular pulmonary stenosis. Brit. Heart J. 22, 686 (1960).PubMedGoogle Scholar
  346. Nimura, Y., Nagata, S., Sakakibara, H., Beppu, S., Park, Y.D., Kinoshita, N., Miyatake, K.: Newer aspects in hypertrophic cardiomyopathy, studied with cross-sectional echocardiography. In: Cardiomyopathy. Clinical, Pathological and Theoretical Aspects (M. Sekiguchi, E.G.J. Olsen, Hrsg.), S. 13. Baltimore: University Park Press 1980.Google Scholar
  347. van Noorden, S., Olsen, E.G.J., Pearse, A.G.E.: Hypertrophic obstructive cardiomyopathy, a histological, histochemical and ultrastructural study of biopsy material. Cardiovasc. Res. 5,118(1971).Google Scholar
  348. Oakley, C.M.: Clinical definitions and classification of cardiomyopathies. Postgrad, med. J. 48, 703 (1972).Google Scholar
  349. Oakley, C.M.: Clinical recognition of the cardiomyopathies. Circulat. Res. Suppl.II, 152 (1974).Google Scholar
  350. Oakley, C.M.: Surgical correction of ASH (letter to the editor). Circulation 51, 951 (1975).PubMedGoogle Scholar
  351. Oakley, C.M.: Diagnosis and natural history of congested (di-lated) cardiomyopathies. Postgrad, med. J. 54, 440 (1978).Google Scholar
  352. Olsen, E.G.J.: Pathology of primary cardiomyopathies. Postgrad. med. J. 48, 732 (1972).PubMedGoogle Scholar
  353. Olsen, E.G.J.: Zur Pathologie der Kardiomyopathien. Schwerpunkt Medizin 2, 103 (1978).Google Scholar
  354. Opherk, D., Zebe, H., Schuler, G., Weihe, E., Mall, G., Mehmel, H., Gravert, B., Kübler, W.: Reduced coronary reserve and impaired exercise left ventricular performance on patients with syndrome x. In: Microcirculation of the Heart - Theoretical and Clinical Problems ( W. Kübler, H. Tillmanns, H. Zebe, Hrsg.). Berlin-Heidelberg-New York: Springer 1980.Google Scholar
  355. Pachinger, O., Klicpera, M., Sochor, H., Probst, P., Kaliman, J., Glogar, D., Mayr, H., Mlczoch, J., Kaindl, F.: Hämodynamik der kongestiven Kardiomyopathie. Z. Kardiol. 71, 509 (1982).PubMedGoogle Scholar
  356. Parillo, J.E., Borsy, G.C., Mazur, M.H., Iannini, P., Klempner, M.S., Moellering, R.C., Anderson, S.E.: Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis. New Engl. J. Med. 300, 296 (1979).Google Scholar
  357. Parker, J.O., West, R.O., Case, R.B., Chiong, M.A.: Temporal relationships of myocardial lactate metabolism, left ventricular function, and ST-segment depression during angina precipitated by exercise. Circulation 40, 97 (1969).PubMedGoogle Scholar
  358. Petersen, J., Rentrop, P., Schnellbacher, K., Roskamm, H., Nitsche, K.: Hämodynamik und Ventrikelmechanik bei nicht koronarbedingter Myokarderkrankung. Z. Kardiol. Suppl. 2, 11 (1975).Google Scholar
  359. Pichard, A.D., Meller, J., Teichholz, L.E., et al.: Septal perforator compression (narrowing) in idiopathic hypertrophic subaortic stenosis. Amer. J. Cardiol. 40, 310 (1977).PubMedGoogle Scholar
  360. Pitcher, D., Wainwright, R, Maisey, M., et al.: Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Brit. Heart J. 44, 650 (1980).PubMedGoogle Scholar
  361. Poche, R.: Pathologie der Kardiomyopathien und Myokardiopathien. In: Herzkrankheiten, 2. Aufl. (H. Roskamm, H. Reindell, Hrsg.), S. 1055. Berlin-Heidelberg-New York: Springer 1982.Google Scholar
  362. Popp, R.L., Harrison, D.C.: Ultrasound in the diagnosis and evaluation of therapy of idiopathic hypertrophic subaortic stenosis. Circulation 50, 905 (1969).Google Scholar
  363. Rakowski, H., Boughner, D.R., Sole, M.J., Wigle, E.D.: The echocardiographic diagnosis of amyloid cardiomyopathy. Circulation 54, Suppl.II, 84 (1976).Google Scholar
  364. Redwood, D.R., Schwerer, J.L., Epstein, S.E.: Biventricular cineangiography in the evaluation of patients with asymmetric septal hypertrophy. Circulation 49, 1116 (1974).PubMedGoogle Scholar
  365. Rees, A., Elbl, F., Minhas, K., Solinger, R.: Echocardiographic evidence of outflow tract obstruction in Pompe’s disease (glycogen storage disease of the heart). Amer. J. Cardiol. 37, 1103 (1976).PubMedGoogle Scholar
  366. Reindell, H., Schildge, E., Klepzig, H., Kirchhoff, H.W.: Kreislaufregulation. Stuttgart: Thieme 1955.Google Scholar
  367. Reindell, H., Görnandt, L., Bubenheimer, P., Dickhuth, H.H.: Kardiomyopathien. In: Funktionsdiagnostik des gesunden und kranken Herzens (H. Reindell, P. Bubenheimer, H.H. Dickhuth, L. Görnandt, Hrsg.), S. 230. Stuttgart: Thieme 1988.Google Scholar
  368. Roberts, W.C., Ferrans, V.J.: Pathologie anatomy of the cardiomyopathies. Hum. Path. 6, 287 (1975).PubMedGoogle Scholar
  369. Roeske, W.R., O’Rourke, R.A., Klein, A., Leopold, G., Karliner, J.S.: Noninvasive evaluation of ventricular hypertrophy in professional athletes. Circulation 53, 286 (1976).PubMedGoogle Scholar
  370. Rosenbaum, M.N.: Chagasic myocardiopathy. Progr. cardiovasc. Dis. 7, 199 (1964).Google Scholar
  371. Rosenblum, R., Delman, A.J.: Valsalva’s maneuver and the systolic murmur of hypertrophic subaortic stenosis: A bedside diagnostic test. Amer. J. Cardiol. 15, 868 (1965).PubMedGoogle Scholar
  372. Rosing, D.R., Kent, K.M., Borer, J.S., Seides, S.F., Maron, B.J., Epstein, S. E.: Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: I.Hemodynamic effects. Circulation 60, 1201 (1979 a).Google Scholar
  373. Rosing, D.R., Kent, K.M., Maron, B.J., Epstein, S.E.: Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: II. Effects on exercise capacity and symptomatic status. Circulation 60, 1208 (1979 b).Google Scholar
  374. Rosing, D.R., Condit, J.R., Maron, B.J., Kent, K.M., Leon, M.B., Bonow, R.O., Lipson, L.C., Epstein, S.E.: Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III.Effects of long-term administration. Amer. J. Cardiol. 48, 545 (1981).PubMedGoogle Scholar
  375. Roskamm, H., Blümchen, G., Fiebig, H., Schnellbacher, K., Wink, K., Papst, K., Schollmeyer, P., Lösel, E., Weidemann, H., Reindell, H.: Hämodynamik und Kontraktilitätsreserve bei Myokardiopathien. Dtsch. med. Wschr. 44, 1681 (1972).Google Scholar
  376. Ross, jr. J., Braunwald, E., Gault, J.H., et al.: The mechanism of the interventricular pressure gradient in idiopathic hypertrophic subaortic stenosis. Circulation 34, 558 (1966).PubMedGoogle Scholar
  377. Rossen, R.M., Goodman, D.J., Ingham, R.E., Popp, R.L.: Ventricular systolic septal thickening and excursion in idiopathic hypertrophic subaortic stenosis. New Eng. J. Med. 291, 1317 (1974).PubMedGoogle Scholar
  378. Rossen, R.M., Goodman, D.J., Ingham, RE., Popp, R.L.: Echocardiographic criteria in the diagnosis of idiopathic hypertrophic subaortic stenosis. Circulation 50, 747 (1974).PubMedGoogle Scholar
  379. Rothlin, M., Turina, J., Krayenbühl, H.P., Senning, A.: Spätresultate nach Operation bei hypertropher obstruktiver Kardiomyopathie. Z. Kardiol. Suppl. 2, 20 (1975).Google Scholar
  380. Rothlin, M., Arbenz, U., Krayenbühl, H.P., Turina, J., Senning, A.: Spätresultate nach Operationen bei muskulärer subvalvulärer Aortenstenose. Z. Kardiol. 65, 501 (1976).PubMedGoogle Scholar
  381. Rubin, K.A., Morrison, J., Padnick, M.B., et aL: Idiopathic hypertrophic subaortic stenosis: Evaluation of anginal symptoms with thallium-201 myocardial imaging. Amer. J. Cardiol. 44, 1040 (1979).PubMedGoogle Scholar
  382. Rudolph, W., Bernsmeier, A.: Klinische und hämodynami- sche Befunde bei Myokarditis mit ausgeprägter Myokardfibrose und ihre Abgrenzung von der Pericarditis constrictiva. Z. Kreisl.-Forsch. 51, 52 (1962).Google Scholar
  383. Ruebsamen, M., Wessel, G.: Das Loefgren-Syndrom. Med. Klin. 65, 1577 (1970).Google Scholar
  384. Sainani, G.S., Krompotic, E., Slodki, S.J.: Adult heart disease due to the Coxsackie Virus-B infection. Medicine (Baltimore) 47, 133 (1968).Google Scholar
  385. Sanders, V.: Idiopathic disease of myocardium. A prospective study. Arch, intern. Med. 112, 661 (1963).Google Scholar
  386. Sanders, V.: The role of “altered antigen” in the production of myocarditis. Circulation Suppl.38 VI, 170 (1968).Google Scholar
  387. Sanders, V., Favour, C.B.: Myocarditis: Infectious and im-munologic aspects. Med. Ann. (D.C.) 31, 310 (1962).Google Scholar
  388. Sanderson, J.E., Traill, T.A., St. John Sutton, M.G.,.: Left ventricular relaxation and filling in hypertrophic cardiomyopathy: An echocardiographic study. Brit. Heart J. 40, 596 (1978).Google Scholar
  389. Saphir, O.: Myokarditis. Amer. Heart J. 57, 639 (1959).PubMedGoogle Scholar
  390. Savage, D.D., Seides, S.F., Marón, B.J., Myers, D.J., Epstein, S. E.: Prevalence of arrhythmias during 24-hours electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 59, 866 (1979).PubMedGoogle Scholar
  391. Savage, D.D., Drayer, J.I.M., Henry, W.L., Matthews, E.C, Ware, J.H., Gardin, J.M., Cohen, E.R., Epstein, S.E., Laraugh, J.H.: Echocardiographic assessment of cardiac function in hypertensive subjects. Circulation 59, 623 (1979).PubMedGoogle Scholar
  392. Scheuer, J.: Metabolism of the heart in heart failure. Progr. cardiovasc. Dis. 13, 24 (1970).Google Scholar
  393. Schmaltz, A.A., Seitz, K.H., Schenck, W., Both, A., Kraus, B.: Restriktive Kardiomyopathie als Spätfolge einer Influenzal-Virus-Myokarditis. Z. Kardiol. 75, 605 (1986).PubMedGoogle Scholar
  394. Schmidt, E., Bender, F., Bachour, G., Gradaus, D.: Provokationstests in der Diagnostik der idiopathisch hypertrophen Subaortenstenose. Z. Kardiol. Suppl. 2, 29 (1975).Google Scholar
  395. Schneider, J.F., Emerson, T.H., Kreger, B.E., McÑamara, P.M., Kannel, W.B.: Newly acquired left bundle branch block: The Framingham study. Ann. intern. Med. 90, 303 (1978).Google Scholar
  396. Schneider, K.W., Jesse, R., Deeg, P., Olsen, E.G.J., Romen, W.: Differentialdiagnose der Kardiomyopathien durch die endomyokardiale Katheterbiopsie. Z. Kardiol. Suppl. 2, 24 (1975).Google Scholar
  397. Schölmerich, P.: Myokarditis und weitere Myokardiopathien. In: Handbh. Inn. Med. Bd IX/II, S. 869. Berlin-Göttingen-Heidelberg: Springer 1960.Google Scholar
  398. Schölmerich, P.: Pathogenese und Klinik der Myokarditis. Ärztl. Prax. 19, 1111 (1967).Google Scholar
  399. Schölmerich, P.: Klinik der Myokarditis. Verh. dtsch. Ges. inn. Med. 77, 335 (1971).PubMedGoogle Scholar
  400. Schölmerich, P.: Diagnostik und Verlauf der Virusmyokarditis. Internist 16, 508 (1975).PubMedGoogle Scholar
  401. Schulte, H.D., Bircks, W., Körfer, R., Kuhn, H.: Surgical aspects of typical subaortic and atypical midventricular hypertrophic obstructive cardiomyopathy (HOCM). Thorac. cardiovasc. Surg. 29, 375 (1981).PubMedGoogle Scholar
  402. Schweizer, P., Hanrath, P., Bleifeld, W., Effert, S.: Echokardiopgraphische Reihenuntersuchungen zur Frage der familiären Häufigkeit der asymmetrischen Septumhypertrophie. Z. Kardiol. Suppl. 2, 13 (1975).Google Scholar
  403. Scovil, J.A., Nanda, N.C., Gross, C.M., Lombardi, A.C., Gramiak, R., Lipchik, E.O., Manning, J.A.: Echocardiographic studies of abnormalities associated with coarctation of the aorta. Circulation 53, 953 (1976).PubMedGoogle Scholar
  404. Segal, J., Harvey, P., Gurel, T.: Diagnosis and treatment of primary myocardial disease. Circulation 32, 837 (1965).PubMedGoogle Scholar
  405. Senn, M., Hess, O.M., Krayenbühl, H.P.: Hypertrophe Kardiomyopathie und Lentiginose. Schweiz, med. Wschr. 114, 838 (1984).Google Scholar
  406. Senning, A.: Transventricular relief of idiopathic hypertrophic subaortic stenoses. J. cardiovasc. Surg. 17, 371 (1976).Google Scholar
  407. Senning, A., Rothlin, M.: Chirurgie bei hypertropher ob-struktiver Kardiomyopathie. Z. Kardiol. 71, 806 (1982).PubMedGoogle Scholar
  408. Shah, P.M., Gramiak, R., Kramer, D.H.: Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 40, 3 (1969).PubMedGoogle Scholar
  409. Shah, P.M., Gramiak, R., Adelman, A.G., Wigle, E.D.: Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis. Circulation 44, 891 (1971).PubMedGoogle Scholar
  410. Shah, P.M., Gramiak, R., Adelman, A.G., Wigle, E.D.: Echocardiographic assessment of the effects of outflow obstruction in hypertrophic subaortic stenosis. Circulation 45, 516 (1972).PubMedGoogle Scholar
  411. Shah, P.M., Adelman, A.G., Wigle, E.F., Gobel, F.L., Bruchell, H.B., Hardarson, T., Curiel, R., Caldaza, C., Oakley, C.M., Goodwin, J.F.: The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circulat. Res. 35/36 (Suppl. 2 ), 179 (1974).Google Scholar
  412. Simon, A.L., Ross, J., Gault, J.H.: Angiograhic anatomy of the left ventricle and mitral valve in idiopathic subaortic stenosis. Circulation 36, 852 (1967).PubMedGoogle Scholar
  413. Smith, M.R., Agruss, N.S., Levenson, N.I., Adolph, R.J.: Non-obstructive hypertrophic cardiomyopathy mimicking mitral stenosis. Amer. J. Cardiol. 35, 89 (1975).PubMedGoogle Scholar
  414. Smith, W.G.: Coxsackie B myocarditis in adults. Amer. Heart J. 80, 34 (1970).PubMedGoogle Scholar
  415. Somerville, J., Bonham-Carter, R.E.: The heart in lentiginosis. Brit. Heart J. 34, 58 (1972).PubMedGoogle Scholar
  416. Sonntag, F., Hanrath, P., Diemert, J., Bleifeld, W.: Klinische und hämodynamische Befunde in Ruhe und unter Belastung bei Patienten mit hypertropher Kardiomyopathie vor und nach hochdosierter Langzeitbehandlung mit Verapamil. Z. Kardiol. 70, 627 (1981).Google Scholar
  417. Spencer, W.H.III, Thornsberry, C, Moody, M.D.: Rheumatic fever chemoprophylaxis and penicillin-resistant gingival organisms. Ann. intern. Med. 58, 683 (1970).Google Scholar
  418. Spiller, P., Brenner, K., Kreuzer, H., Neuhaus, K. L., Niessen, H.W.: Systolische Ventrikel- und Myokardfunktion bei hypertrophischer obstruktiver Kardiomyopathie. Z. Kardiol. Suppl. 2, 8 (1975).Google Scholar
  419. Staemmler, M.: Die isolierte (Fiedlersche) Myokarditis. Veröff. Pathol. 65. Stuttgart: Fischer 1962.Google Scholar
  420. Stapleton, J.F., Segal, J.P., Harvey, W.P.: The electrocardiogram of myocardiopathy. Progr. cardiovasc. Dis. 13, 217 (1970).Google Scholar
  421. Stapleton, J.F., Segal, J.P., Harvey, W.P.: Clinical pathway of cadiopathies. Circulât. Res. 34/35 (Suppl. 2 ), 168 (1974).Google Scholar
  422. Stenson, R.E., Flamm, jr. M.D., Harrison, D.C., et al.: Hypertrophic subaortic stenosis: Clinical and hemodynamic effects of long-term propranolol therapy. Amer. J. Cardiol. 31, 763 (1973).PubMedGoogle Scholar
  423. St. John Sutton, M.G., Tajik, A.J., Gibson, D.G., Brown, D.J., Seward, J.B., Giuliani, E.R.: Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis. Circulation 57, 512 (1978).Google Scholar
  424. St.John Sutton, M.G., Tajik, A.J., Smith, H.C.,.: Angina in idiopathic hypertrophic subaortic stenosis: A clinical correlate of regional left ventricular dysfunction; a videometric and echocardiographic study. Circulation 61, 561 (1980).Google Scholar
  425. St.John Sutton, M.G., Olukotun, A.Y., Tajik, A.J.,.: Left ventricular function in Friedreich’s ataxia: An echocardiographic study. Brit. Heart J. 44, 309 (1980).Google Scholar
  426. St.John Sutton, M.G., Tajik, A.J., Guiliani, E.R.,.: Hypertrophic obstructive cardiomyopathy and lentiginosis: A little known neural ectodermal syndrome. Amer. J. Cardiol. 47, 214 (1981).Google Scholar
  427. St. John Sutton, M.G., Lie, J.T., Tajik, A. J., Danielson, G.K., Frye, R.L.: Hypertrophic obstructive cardiomyopathy. Heart Failure 1, 4 (1985).Google Scholar
  428. Storstein, O.: Primary myocardial disease. Acta med. scand. 176, 731 (1964).PubMedGoogle Scholar
  429. Storstein, O.: Hemodynamic studies in primary myocardial disease. Acta med. scand. Suppl. 113, 472 (1967).Google Scholar
  430. Strauer, B.E.: Die hypertrophische obstruktive Kardiomyopathie. Internist 16, 530 (1975).PubMedGoogle Scholar
  431. Strauer, B.E., Bolte, H., Heimburg, P., Riecker, G.: Zur koronaren Herzkrankheit II.: Eine Analyse diastolischer Druck-Volumen-Beziehungen und linksventrikulärer Dehn¬barkeit an 110 Patienten. Z. Kardiol. 64, 311 (1975).PubMedGoogle Scholar
  432. Strauer, B. E., Kramer, H., Avenhaus, H., Bolte, H., Lüderitz, B., Neubaur, J., Riecker, G.: Hämodynamik, Volumina und Dehnbarkeit des linken Ventrikels bei 167 Patienten mit angeborenen und erworbenen Herzfehlern. Klin. Wschr. 53, 961 (1975).PubMedGoogle Scholar
  433. Strunk, B.L., Guss, S.B., Hicks, R.E., Kotler, M.N.: Echocardiography recognition of the mitral valve posterior aortic wall relationship. Circulation 51, 594 (1975).PubMedGoogle Scholar
  434. Sunil, K., Dodson, D., Dodson, V.N.: Immunglobulin binding in cardiomyopathic heart. Circulation Suppl. 39/III, 66 (1969).Google Scholar
  435. Sutton, G.C., Demakis, J.A., Anderson, T.O., Morrissey, R.A.: Serologie evidence of a sporadie outbreak in Illinois of infection by chlamydia (psittacosis-Lgv agent) in patients with primary myocardial disease and respiratory disease. Amer. Heart J. 81, 597 (1971).PubMedGoogle Scholar
  436. Swan, D.A., Bell, B., Oakley, C.M., et al.: Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Brit. Heart J. 33, 671 (1971).PubMedGoogle Scholar
  437. Tajik, A.J., Giuliani, E.R., Weidman, W.H., et al.: Idiopathic hypertrophic subaortic stenosis: Long-term surgical follow-up. Amer. J. Cardiol. 34, 815 (1974).PubMedGoogle Scholar
  438. Takatsu, T.: Idiopathic cardiomyopathy. Jpn. J. Med. 17, 157 (1978).Google Scholar
  439. Tauchert, N., Behrenbeck, D.W., Hötzel, J., Hombach, V., Jansen, W., Niehus, B., Obst, H.P., Hilger, H.H.: Funktioneller Nachweis der small vessel disease. Verh. dtsch. Ges. Kreisl. Forsch. 172 (1978).Google Scholar
  440. Teare, R. D.: Asymmetrical hypertrophy of the heart in young adults. Brit Heart J. 20, 1 (1958).PubMedGoogle Scholar
  441. Thaulow, E., Eriksson, J., Nitter-Hauge, S., Rootwelt, K.: False positive exercise test - a sign of cardiomyopathy? Europ. Congr. Cardiol, (abstract-book 127 ) 1980.Google Scholar
  442. Traill, T.A., Gibson, D.G., Brown, D.J.: Study of left ventricular wall thickness and dimension changes using echocardiography. Brit. Heart J. 40, 162 (1978).PubMedGoogle Scholar
  443. Trieb, G., Sigwart, H., Mannebach, H., Gleichmann, U.: Segmentale frühzeitige Relaxation (SERP) des linken Ventrikels in Ruhe vs. ischämieinduzierter Hypokinesie im Belastungsangiogramm - eine Korrelationsstudie. Z. Kardiol. 68, 520 (1979).PubMedGoogle Scholar
  444. Vecht, R.J., Oakley, C.M.: Infective endocarditis in three patients with hypertrophic obstructive cardiomyopathy. Brit, med. J. 2, 455 (1968).Google Scholar
  445. Watt, A.: Hypertrophic cardiomyopathy; a disease of impaired adenosine mediated autoregulation of the heart. Lancet 1, 1271 (1984).PubMedGoogle Scholar
  446. Weiss, M.B., Ellis, K., Sciacca, R.R., et al.: Myocardial blood flow in congestive and hypertrophic cardiomyopathy: Relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation 54, 484 (1976).PubMedGoogle Scholar
  447. Wenger, R.: Endokardfibrosen. Stuttgart: Thieme 1964.Google Scholar
  448. Wenger, R.: Endomyokardfibrosen. Verh. dtsch. Ges. inn. Med. 77, 65 (1971).PubMedGoogle Scholar
  449. Whalen, R.E., Cohen, A.I., Summer, R.G., et al.: Demonstration of the dynamic nature of idiopathic hypertrophic subaortic stenosis. Amer. J. Cardiol. 11, 8 (1963).PubMedGoogle Scholar
  450. Whiting, R.B., Powell jr., W.J., Dinsmore, R.E., et al.: Idiopathic hypertrophic subaortic stenosis in the elderly. N. Engl. J. Med. 96, 326 (1971).Google Scholar
  451. WHO: Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Brit. Heart J. 44, 672 (1980).Google Scholar
  452. Wigle, E.D.: Muscular subaortic stenosis: The clinical syndrome, with additional evidence of ventricular septal hypertrophy. In: Ciba Foundation Symposium on Cardiomyopathies (G.E.W. Wolstenholme, M. O’Connor, Hrsg.), S. 49. London: Churchill Livingstone 1964.Google Scholar
  453. Wigle, E.D., Silver, M.D.: Myocardial fiber disarray and ventricular septal hypertrophy in asymmetrical hypertrophy of the heart. Circulation 58, 398 (1978).PubMedGoogle Scholar
  454. Wigle, E.D., Felderhof, C.H., Silver, M.D., Adelman, A.G.: Hypertrophic obstructive cardiomyopathy. In: Myocardial diseases (E.D. Fowler, Hrsg.), S. 297. New York: Grune & Stratton 1973.Google Scholar
  455. Wigle, E.D., Adelman, A.G., Felderhof, C.H.: Medical and surgical treatment of the cardiomyopathies. Circulât. Res. 34/35 (Suppl. 2 ), 196 (1974).Google Scholar
  456. Wigle, E.D., Sasson, Z., Henderson, M.A., Ruddy, T.D., Fulop, J., Rakowski, H., Williams, W.G.: Hypertrophic cardiomyopathy, the importance of the site and the extent of hypertrophy. A review. Prog, cardiovasc. Dis. 28, 1 (1985).Google Scholar
  457. Wilson, F.M., Miranda, Q.R., Chason, J.L., Lerner, A.M.: Residual pathologic changes following murine Coxsackie A and B myocarditis. Amer. J. Path. 55, 253 (1969).PubMedGoogle Scholar
  458. Windorfer, A.: Die akute Virus-Myokarditis beim Kind. Münch, med. Wschr. 108, 2213 (1966).Google Scholar
  459. Wink, K., Hagemann, G., Brett, W., Barmeyer, J., Reindell, H.: Verlaufsbeobachtungen bei verschiedenen Formen der Kardiomyopathien. Z. Kardiol. Suppl. 2, 18 (1975).Google Scholar
  460. Witzke, D.J., Kay, M.P.: Hypertrophie cardiomyopathy induced by administration of nerve growth factor (abstract). Circulation 54 (suppl. 2), 88 (1976).Google Scholar
  461. Woodward, T.E., McCrumb, jr. F.R., Carey, T.N., Togo, Y.: Viral and rickettsial causes of cardiac disease, including the coxsackie virus etiology of pericarditis and myocarditis. Ann. intern. Med. 53, 1130 (1960).Google Scholar
  462. Yamaguchi, H., Ischimura, T., Nishiyama, S., Nagasaki, F., Nakanishi, S., Takatsu, F., Nishija, T., Umeda, T., Machii, K.: Hypertrophic non obstructive cardiomyopathy with giant negative T-waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Amer. J. Cardiol. 44, 401 (1979).PubMedGoogle Scholar
  463. Yu, P.N., Schreiner, B.F., Cohen, J., Murphy, G.W.: Idiopathic cardiomyopathy. A study of left ventricular function and pulmonary circulation in 15 patients. Amer. Heart J. 71, 330 (1966).PubMedGoogle Scholar
  464. Zebe, H., Mall, G.: Die Myokarditis. Dtsch. Ärztebl. 33, 2089 (1979).Google Scholar
  465. Zöllner, N., Lydtin, H.: Über ein gehäuftes Auftreten patho-logischer Herzbefunde bei Coxsackie-Infektionen Erwachsener. Dtsch. med. Wschr. 92, 2049 (1967).PubMedGoogle Scholar

Literatur (Abschnitt 48.10 und 48.11)

  1. Alexander, C.S., Nino, A.: Cardiovascular complications in young patients taking psychotherapeutic drugs. Amer. Heart J. 78, 757 (1969).PubMedGoogle Scholar
  2. Alexander, J., Dainiak, N., Berger, H.J., Goldmann, L., Johnstone, D., Reduto, L., Duffy, T., Schwartz, P., Gottschalk, A., Zaret, B.L.: Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. New Engl. J. Med. 300, 278 (1979).PubMedGoogle Scholar
  3. Appelbaum, F., Sträuchen, J.A., Graw jr., R.G.: Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet 1976 I, 58.Google Scholar
  4. Blanc, F., Siguier, F.: L’amibiase: étude clinique et thérapeutique. L L’expansion scientifique française (1950).Google Scholar
  5. Bloom, K.R., Bini, R.M., Williams, C.M., Sonley, M.J., Gribbin, M.A.: Echocardiography in adriamycin cardiotoxicity. Cancer 41, 1265 (1978).PubMedGoogle Scholar
  6. Blum, R.H., Carter, S.K.: Adramycin: A new anti-cancer drug with significant clinical activity. Ann. intern. Med. 80, 249 (1974).PubMedGoogle Scholar
  7. Bouvrain, Y., Roujeau, J., Rogard, J.M.: Myocardite postradiothérapeutique. Sem. Hop. Paris 53, 433 (1977).PubMedGoogle Scholar
  8. Brem, T.H., Konwaller, B.E.: Fetal myocarditis due to emetine hydrochloride. Amer. Heart J. 50, 477 (1955).Google Scholar
  9. Burch, G.E., Sohal, R.S., Sun, J.C., Miller, J.C., Colcolough, H.L.: Effects of radiation on the human heart. An electron microscopic study. Arch, intern. Med. 121, 230 (1968).Google Scholar
  10. Catteral, M., Evans, W.: Myocardial injury from thérapeutique irradiation. Brit. Heart J. 22, 168 (1960).Google Scholar
  11. Cohnen, G.: Arzneimittelinduzierte Lupus-erythematodesâhnliche Syndrome. Med. Klin. 71, 789 (1976).Google Scholar
  12. Demers, R.G„ Heninger, G.R.: Electrocardiographic changes during lithium carbonate treatment. J. Amer. med. Ass. 218, 381 (1971).Google Scholar
  13. Dempsy, J.J., Salem, H.H.: An enzymatic electrocardiographic study on toxicity of dehydroemetine. Brit. Heart J. 28, 505 (1966).Google Scholar
  14. Desautels, S., Filteau, C., St.Jean, A.: Ventricular tachycardia associated with administration of thioridaxine hydrochloride. Canad. med. Ass. J. 90, 1030 (1964).PubMedGoogle Scholar
  15. Di Matteo, J., Vacheron, A., Heulin, A., Meeus, L., Di Matteo, G., Gilles, R., Delage, F., De Ratuld, A.: Complications cardiaques de la radiothérapie thoracique. Arch. Mal. Coeur 71, 447 (1978).PubMedGoogle Scholar
  16. Dollinger, M.R., Lavine, D.M., Foye, L.V.: Myocardial infarction due to post-irradiation fibrosis of the coronary arteries. J. Amer. med. Ass. 195, 316 (1966).Google Scholar
  17. Fajardo, L.F., Stewart, J.R.: Experimental radiation-induced heart disease. Amer. J. Pathol. 59, 299 (1970).Google Scholar
  18. Fajardo, L.F., Stewart, J.R.: Pathogenesis of radiation induced myocardial fibrosis. Lab. Invest. 29, 244 (1973).PubMedGoogle Scholar
  19. Fanger, H., Lushbaugh, C.C.: Radiation death from cardiovascular shock following accident. Arch. Pathol. 83, 446 (1967).PubMedGoogle Scholar
  20. Fowler, N.O., McCall, D., Chou, T.: Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Amer. J. Cardiol. 37, 223 (1976).PubMedGoogle Scholar
  21. Giard, P., Crinquette, J.: Cardiomyopathie radiothérapique: mécanisme pathogénique par autoanticorps. Sem. Hôp. Paris 46, 923 (1970).PubMedGoogle Scholar
  22. Greenwood, R.D., Rosenthal, A., Cassady, R., Jaffee, N., Nadas, A.S.: Constrictive pericarditis in childhood due to mediastinal irradiation. Circulation 50, 1033 (1974).PubMedGoogle Scholar
  23. Guérin, R.A., Chenal, C., Dali Youcef, F.: Conditions cliniques et techniques d’apparition des complications endothoraciques des irritations externes. Rev. fr. Mal. resp. 5, 283 (1977).Google Scholar
  24. Haiat, R., Uzan, C., Chiche, P.: Action cardiovasculaire du lithium. Coeur Med. int. 6, 251 (1977).Google Scholar
  25. Halazoun, J.F., Wagner, H.R., Geata, J.F.: Daunorubicin cardiac toxicity in children with acute lymphocytic leukemia. Cancer 33, 545 (1974).Google Scholar
  26. Harrison, E.T., Sanders, L.A.: Pericarditis in a early case of daunorubicin cardiomyopathy. Ann. intern. Med. 85, 339 (1976).PubMedGoogle Scholar
  27. Honey, M.: The effects of sodium antimony tartrate on the myocardium. Brit. Heart J. 22, 601 (1960).PubMedGoogle Scholar
  28. Jefferson, J.W.: A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom. Med. 37, 160 (1975).PubMedGoogle Scholar
  29. Keelan jr., M.H., Rudders, R.A.: Successful treatment of radiation pericarditis with corticosteroids. Arch, intern. Med. 134, 145 (1974).Google Scholar
  30. Lefrak, E.A., Pitha, J., Rosenheims, S., O’Bryan, R.M., Burgess, M.A., Gottlieb, M.A.: Adriamycin (NCS-123127) cardiomyopathy. Cancer Chemother. Rep. a, 195 (1975).Google Scholar
  31. Lenarz, L., Page, J.A.: Cardiotoxicity of Adriamycin and related anthracyclines. Cancer Treat. Rev. 3, 111 (1976).Google Scholar
  32. Levine, D.G., Marshall, A.J.: Cardiac arrhythmias induced by phenothiazine. Lancet 1975 II, 990.Google Scholar
  33. Lindsay, S., Kohn, H.J., Dakin, R.L., Jew, J.: Aortic arteriosclerosis in the dog after localized aortic x-radiation. Circulât. Res. 10, 51 (1962).PubMedGoogle Scholar
  34. McReynolds, R.A., Gold, D.L., Roberts, W.C.: Coronary heart disease after mediastinal irradiation for Hodgkin’s disease. Amer. J. Med. 60, 39 (1976).PubMedGoogle Scholar
  35. Michael, T.A.D., Arivazzadek, S.: The effects of acute chloroquine poisoning with special reference to the heart. Amer. Heart J. 70, 831 (1970).Google Scholar
  36. Mikhail, J. R., et al.: Abnormal electrocardiographic findings in sarcoidosis. Proc. VI ICS Univ. Tokyo Press 365 (1975).Google Scholar
  37. Minow, R.A., Benjamin, R.S., Gottlieb, J.A.: Adriamycin (NCS-123127) cardiomyopathy. An overview with determination of risk factors. Cancer Chemother. Rep. 6, 195 (1975).Google Scholar
  38. Minow, R.A., Benjamin, R.S., Lee, E.T., Gottlieb, J.A.: Adriamycin cardiomyopathy-risk factors. Cancer 39, 1397 (1977).PubMedGoogle Scholar
  39. Morin, Y., Cote, S.K.: Toxic agents and cardiomyopathies. Cardiovasc. Clin. 4, 245 (1972).PubMedGoogle Scholar
  40. Morton, D.L., Glancy, D.L., Joseph, W.L., Adkins, P.L.: Management of patients with radiation induced pericarditis with effusion. Chest 64, 291 (1973).PubMedGoogle Scholar
  41. Motte, G., Waynberger, M., Bailly, J., Sicard, D., Chelloul, N.: Myocarditis émétienne. A propos d’un cas mortel dû à la 2-dehydroémétine. Ann. Med. int. (Paris) 12, 979 (1970).Google Scholar
  42. Murphy, M.L., Bullock, R.T., Pearce, M.B.: The correlation of metabolic and ultrastructural changes in emetine myocardial toxicity. Amer. Heart J. 87, 105 (1974).PubMedGoogle Scholar
  43. O’Connel, T.X., Berenbaum, M.D.: Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide. Cancer Res. 34, 1586 (1974).Google Scholar
  44. Pearce, M.B., Bullock, R.T., Murphy, M.L.: Selective damage of mitochondria due to emetine hydrochloride. Arch. Pathol. 91, 8 (1971).PubMedGoogle Scholar
  45. Prentice, R.: Myocardial infarction following radiation. Lancet 1965 II, 388.Google Scholar
  46. Raisfeld, I.H.: Cardivascular complications of antidepressant therapy. Interactions at the adrenergic neuron. Amer. Heart J. 83, 129 (1972).PubMedGoogle Scholar
  47. Richardson, H.L., Graupner, H.E., Richardson, M.E.: Intramyocardial lesions in patients dying suddenly and unexpectedly. J. Amer. med. Ass. 195, 254 (1966).Google Scholar
  48. Rinehart, J.J., Lewis, R.P., Balcerzak, S.P.: Adriamycin cardiotoxicity in man. Ann. intern. Med. 81, 475 (1974).PubMedGoogle Scholar
  49. Roberts, W.C., Ferrans, V.J.: Pathologic anatomy of the cardiomyopathies. Hum. Path. 6, 287 (1975).PubMedGoogle Scholar
  50. Robinson, D.S., Barker, E.: Tricyclic antidepressant cardiotoxicity. J. Amer. med. Ass. 236, 2089 (1976).Google Scholar
  51. Saint-Pierre, A., Perrin, A., Pouzerate, J.P., Favrot, B.: Myocardiopathie chronique induite par Fimipramine. Coeur Med. int. 11, 27 (1972).Google Scholar
  52. Sanghri, L.M., Mathur, B.B.: Electrocardiogram after chloroquine and emetine. Circulation 32, 281 (1965).Google Scholar
  53. Schwartz, J. A.: Medikamentös induzierte Lupus-erythematodesähnliche Erkrankungen. Arzneim.-Forsch. 27, 1856 (1977).Google Scholar
  54. Stewart, J.R., Cohn, K.E., Fajardo, L.F., Hancock, E.N., Kaplan, H.S.: Radiation induced heart disease. Radiology 89, 302 (1967).Google Scholar
  55. Tilkian, A., Schroeder, J.S., Kao, J., Hultgren, H.: Effect of lithium on cardiovascular performance: Report on extended ambulatory monitoring and exercise testing before and during lithium therapy. Amer. J. Cardiol. 38, 701 (1976).PubMedGoogle Scholar
  56. Tseng, H.C.: Interstitial myocarditis probably related to lithium carbonate intoxication. Arch. Pathol. 92, (1971).Google Scholar
  57. Tzivoni, D., Ratzrowski, E., Biran, S., Brook, J.G., Stern, S.: Complete heart block following therapeutic irradiation at the left side of the chest. Chest 71, 231 (1977).PubMedGoogle Scholar
  58. Von Hoff, D.D. La Yard, M.W., Basa, P., Davis, jr. H.L., Von Hoff, A.L., Rosenzweig, M., Muggia, F.M.: Risk factors for doxorubicin-induced congestive heart failure. Ann. intern. Med. 91, 710 (1979).Google Scholar
  59. Weinstein, P., Greenwald, E.S., Grossmann, J.: Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin’s disease. Amer. J. Med. 60, 38 (1976).Google Scholar
  60. Wellens, H.J., Cats, V.M., Duren, D.R.: Symptomatic sinus node abnormalities following lithium carbonate therapy. Amer. J. Med. 59, 285 (1975).PubMedGoogle Scholar
  61. Wenzel, D.G.: Drug induced cardiomyopathies. A preliminary report. J. pharm. Sci. 56, 1209 (1967).PubMedGoogle Scholar
  62. Wilson, J.D.: Antinuclear antibodies and cardiovascular drugs. Drugs 19, 292 (1980).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • H. Reindell
  • L. Görnandt
  • P. Bubenheimer

There are no affiliations available

Personalised recommendations